Search

Free text searches can be performed by entering key words like 'ATP liver' in the text field. This will retrieve all entries containing the search terms (also if only appearing in the publication title).
More sophisticated searches can be performed using the 'Advanced Search' tab. learn more


      
Advanced Search

  • enter search term(s) as free text (like Google)
  • press 'magnification glass' to start search
  • search results will be displayed below (scroll down ↓)
  • select entries (mark checkboxes)
  • if you want to export data, click the checkbox for each entry and finally click on the symbol in the upper right corner to proceed
To improve SABIO-RK data interoperability, semantic markup was added to web pages as described and defined by Bioschemas.
This structured information makes it easier to discover, collate and analyse our data.

SABIO-RK entries

<< back to entry ranges

68001 PPi-dependent phosphofructokinase from Thermoproteus tenax, an archaeal descendant of an ancient line in ...
68002 Enzymatic characteristics of recombinant medium isozyme of 2'-5' oligoadenylate synthetase.
68003 A chloroplastic UDP-glucose pyrophosphorylase from Arabidopsis is the committed enzyme for the first step of ...
68004 A chloroplastic UDP-glucose pyrophosphorylase from Arabidopsis is the committed enzyme for the first step of ...
68005 Functional comparison of citrate synthase isoforms from S. cerevisiae.
68006 Functional comparison of citrate synthase isoforms from S. cerevisiae.
68007 Functional comparison of citrate synthase isoforms from S. cerevisiae.
68008 Deletion mutagenesis using an 'M13 splint': the N-terminal structural domain of tyrosyl-tRNA synthetase (B. ...
68008 Deletion mutagenesis using an 'M13 splint': the N-terminal structural domain of tyrosyl-tRNA synthetase (B. ...
68009 Deletion mutagenesis using an 'M13 splint': the N-terminal structural domain of tyrosyl-tRNA synthetase (B. ...
68009 Deletion mutagenesis using an 'M13 splint': the N-terminal structural domain of tyrosyl-tRNA synthetase (B. ...
68010 Deletion mutagenesis using an 'M13 splint': the N-terminal structural domain of tyrosyl-tRNA synthetase (B. ...
68010 Deletion mutagenesis using an 'M13 splint': the N-terminal structural domain of tyrosyl-tRNA synthetase (B. ...
68011 Deletion mutagenesis using an 'M13 splint': the N-terminal structural domain of tyrosyl-tRNA synthetase (B. ...
68011 Deletion mutagenesis using an 'M13 splint': the N-terminal structural domain of tyrosyl-tRNA synthetase (B. ...
68012 Mechanism of molecular interactions for tRNA-Val recognition by valyl-tRNA synthetase
68012 Mechanism of molecular interactions for tRNA-Val recognition by valyl-tRNA synthetase
68013 Mechanism of molecular interactions for tRNA-Val recognition by valyl-tRNA synthetase
68013 Mechanism of molecular interactions for tRNA-Val recognition by valyl-tRNA synthetase
68014 Mechanism of molecular interactions for tRNA-Val recognition by valyl-tRNA synthetase
68014 Mechanism of molecular interactions for tRNA-Val recognition by valyl-tRNA synthetase
68015 Mechanism of molecular interactions for tRNA-Val recognition by valyl-tRNA synthetase
68015 Mechanism of molecular interactions for tRNA-Val recognition by valyl-tRNA synthetase
68016 Mechanism of molecular interactions for tRNA-Val recognition by valyl-tRNA synthetase
68016 Mechanism of molecular interactions for tRNA-Val recognition by valyl-tRNA synthetase
68017 Mechanism of molecular interactions for tRNA-Val recognition by valyl-tRNA synthetase
68017 Mechanism of molecular interactions for tRNA-Val recognition by valyl-tRNA synthetase
68018 Mechanism of molecular interactions for tRNA-Val recognition by valyl-tRNA synthetase
68018 Mechanism of molecular interactions for tRNA-Val recognition by valyl-tRNA synthetase
68019 Mechanism of molecular interactions for tRNA-Val recognition by valyl-tRNA synthetase
68019 Mechanism of molecular interactions for tRNA-Val recognition by valyl-tRNA synthetase
68020 Mechanism of molecular interactions for tRNA-Val recognition by valyl-tRNA synthetase
68020 Mechanism of molecular interactions for tRNA-Val recognition by valyl-tRNA synthetase
68021 Mechanism of molecular interactions for tRNA-Val recognition by valyl-tRNA synthetase
68021 Mechanism of molecular interactions for tRNA-Val recognition by valyl-tRNA synthetase
68022 Re-citrate synthase from Clostridium kluyveri is phylogenetically related to homocitrate synthase and ...
68022 Re-citrate synthase from Clostridium kluyveri is phylogenetically related to homocitrate synthase and ...
68023 Re-citrate synthase from Clostridium kluyveri is phylogenetically related to homocitrate synthase and ...
68023 Re-citrate synthase from Clostridium kluyveri is phylogenetically related to homocitrate synthase and ...
68024 Re-citrate synthase from Clostridium kluyveri is phylogenetically related to homocitrate synthase and ...
68024 Re-citrate synthase from Clostridium kluyveri is phylogenetically related to homocitrate synthase and ...
68025 Rat malonyl-CoA decarboxylase; cloning, expression in E. coli and its biochemical characterization.
68025 Rat malonyl-CoA decarboxylase; cloning, expression in E. coli and its biochemical characterization.
68026 Cocrystal structures of diaminopimelate decarboxylase: mechanism, evolution, and inhibition of an antibiotic ...
68026 Cocrystal structures of diaminopimelate decarboxylase: mechanism, evolution, and inhibition of an antibiotic ...
68027 Cocrystal structures of diaminopimelate decarboxylase: mechanism, evolution, and inhibition of an antibiotic ...
68027 Cocrystal structures of diaminopimelate decarboxylase: mechanism, evolution, and inhibition of an antibiotic ...
68028 Cocrystal structures of diaminopimelate decarboxylase: mechanism, evolution, and inhibition of an antibiotic ...
68028 Cocrystal structures of diaminopimelate decarboxylase: mechanism, evolution, and inhibition of an antibiotic ...
68029 Cocrystal structures of diaminopimelate decarboxylase: mechanism, evolution, and inhibition of an antibiotic ...
68029 Cocrystal structures of diaminopimelate decarboxylase: mechanism, evolution, and inhibition of an antibiotic ...
68030 Cocrystal structures of diaminopimelate decarboxylase: mechanism, evolution, and inhibition of an antibiotic ...
68030 Cocrystal structures of diaminopimelate decarboxylase: mechanism, evolution, and inhibition of an antibiotic ...
68031 Cocrystal structures of diaminopimelate decarboxylase: mechanism, evolution, and inhibition of an antibiotic ...
68031 Cocrystal structures of diaminopimelate decarboxylase: mechanism, evolution, and inhibition of an antibiotic ...
68032 Cocrystal structures of diaminopimelate decarboxylase: mechanism, evolution, and inhibition of an antibiotic ...
68032 Cocrystal structures of diaminopimelate decarboxylase: mechanism, evolution, and inhibition of an antibiotic ...
68033 Cocrystal structures of diaminopimelate decarboxylase: mechanism, evolution, and inhibition of an antibiotic ...
68033 Cocrystal structures of diaminopimelate decarboxylase: mechanism, evolution, and inhibition of an antibiotic ...
68034 Cocrystal structures of diaminopimelate decarboxylase: mechanism, evolution, and inhibition of an antibiotic ...
68034 Cocrystal structures of diaminopimelate decarboxylase: mechanism, evolution, and inhibition of an antibiotic ...
68035 Plants synthesize ethanolamine by direct decarboxylation of serine using a pyridoxal phosphate enzyme.
68035 Plants synthesize ethanolamine by direct decarboxylation of serine using a pyridoxal phosphate enzyme.
68036 Plants synthesize ethanolamine by direct decarboxylation of serine using a pyridoxal phosphate enzyme.
68036 Plants synthesize ethanolamine by direct decarboxylation of serine using a pyridoxal phosphate enzyme.
68037 Plants synthesize ethanolamine by direct decarboxylation of serine using a pyridoxal phosphate enzyme.
68037 Plants synthesize ethanolamine by direct decarboxylation of serine using a pyridoxal phosphate enzyme.
68038 Partial Purification and Characterization of Red Chlorophyll Catabolite Reductase, a Stroma Protein Involved ...
68038 Partial Purification and Characterization of Red Chlorophyll Catabolite Reductase, a Stroma Protein Involved ...
68039 Allosteric control by calcium and mechanism of desensitization of phosphoenolpyruvate carboxykinase of ...
68039 Allosteric control by calcium and mechanism of desensitization of phosphoenolpyruvate carboxykinase of ...
68040 Allosteric control by calcium and mechanism of desensitization of phosphoenolpyruvate carboxykinase of ...
68040 Allosteric control by calcium and mechanism of desensitization of phosphoenolpyruvate carboxykinase of ...
68041 Allosteric control by calcium and mechanism of desensitization of phosphoenolpyruvate carboxykinase of ...
68041 Allosteric control by calcium and mechanism of desensitization of phosphoenolpyruvate carboxykinase of ...
68042 Allosteric control by calcium and mechanism of desensitization of phosphoenolpyruvate carboxykinase of ...
68042 Allosteric control by calcium and mechanism of desensitization of phosphoenolpyruvate carboxykinase of ...
68043 Allosteric control by calcium and mechanism of desensitization of phosphoenolpyruvate carboxykinase of ...
68043 Allosteric control by calcium and mechanism of desensitization of phosphoenolpyruvate carboxykinase of ...
68044 Allosteric control by calcium and mechanism of desensitization of phosphoenolpyruvate carboxykinase of ...
68044 Allosteric control by calcium and mechanism of desensitization of phosphoenolpyruvate carboxykinase of ...
68045 Allosteric control by calcium and mechanism of desensitization of phosphoenolpyruvate carboxykinase of ...
68045 Allosteric control by calcium and mechanism of desensitization of phosphoenolpyruvate carboxykinase of ...
68046 Allosteric control by calcium and mechanism of desensitization of phosphoenolpyruvate carboxykinase of ...
68046 Allosteric control by calcium and mechanism of desensitization of phosphoenolpyruvate carboxykinase of ...
68047 Allosteric control by calcium and mechanism of desensitization of phosphoenolpyruvate carboxykinase of ...
68047 Allosteric control by calcium and mechanism of desensitization of phosphoenolpyruvate carboxykinase of ...
68048 Allosteric control by calcium and mechanism of desensitization of phosphoenolpyruvate carboxykinase of ...
68048 Allosteric control by calcium and mechanism of desensitization of phosphoenolpyruvate carboxykinase of ...
68049 Allosteric control by calcium and mechanism of desensitization of phosphoenolpyruvate carboxykinase of ...
68049 Allosteric control by calcium and mechanism of desensitization of phosphoenolpyruvate carboxykinase of ...
68050 Allosteric control by calcium and mechanism of desensitization of phosphoenolpyruvate carboxykinase of ...
68050 Allosteric control by calcium and mechanism of desensitization of phosphoenolpyruvate carboxykinase of ...
68051 Allosteric control by calcium and mechanism of desensitization of phosphoenolpyruvate carboxykinase of ...
68051 Allosteric control by calcium and mechanism of desensitization of phosphoenolpyruvate carboxykinase of ...
68052 Allosteric control by calcium and mechanism of desensitization of phosphoenolpyruvate carboxykinase of ...
68052 Allosteric control by calcium and mechanism of desensitization of phosphoenolpyruvate carboxykinase of ...
68053 Allosteric control by calcium and mechanism of desensitization of phosphoenolpyruvate carboxykinase of ...
68053 Allosteric control by calcium and mechanism of desensitization of phosphoenolpyruvate carboxykinase of ...
68054 Allosteric control by calcium and mechanism of desensitization of phosphoenolpyruvate carboxykinase of ...
68054 Allosteric control by calcium and mechanism of desensitization of phosphoenolpyruvate carboxykinase of ...
68055 Allosteric control by calcium and mechanism of desensitization of phosphoenolpyruvate carboxykinase of ...
68055 Allosteric control by calcium and mechanism of desensitization of phosphoenolpyruvate carboxykinase of ...
68056 EH3 (ABHD9): the first member of a new epoxide hydrolase family with high activity for fatty acid epoxides.
68056 EH3 (ABHD9): the first member of a new epoxide hydrolase family with high activity for fatty acid epoxides.
68057 EH3 (ABHD9): the first member of a new epoxide hydrolase family with high activity for fatty acid epoxides.
68057 EH3 (ABHD9): the first member of a new epoxide hydrolase family with high activity for fatty acid epoxides.
68058 EH3 (ABHD9): the first member of a new epoxide hydrolase family with high activity for fatty acid epoxides.
68058 EH3 (ABHD9): the first member of a new epoxide hydrolase family with high activity for fatty acid epoxides.
68059 EH3 (ABHD9): the first member of a new epoxide hydrolase family with high activity for fatty acid epoxides.
68059 EH3 (ABHD9): the first member of a new epoxide hydrolase family with high activity for fatty acid epoxides.
68060 EH3 (ABHD9): the first member of a new epoxide hydrolase family with high activity for fatty acid epoxides.
68060 EH3 (ABHD9): the first member of a new epoxide hydrolase family with high activity for fatty acid epoxides.
68061 EH3 (ABHD9): the first member of a new epoxide hydrolase family with high activity for fatty acid epoxides.
68061 EH3 (ABHD9): the first member of a new epoxide hydrolase family with high activity for fatty acid epoxides.
68062 EH3 (ABHD9): the first member of a new epoxide hydrolase family with high activity for fatty acid epoxides.
68062 EH3 (ABHD9): the first member of a new epoxide hydrolase family with high activity for fatty acid epoxides.
68063 EH3 (ABHD9): the first member of a new epoxide hydrolase family with high activity for fatty acid epoxides.
68063 EH3 (ABHD9): the first member of a new epoxide hydrolase family with high activity for fatty acid epoxides.
68064 EH3 (ABHD9): the first member of a new epoxide hydrolase family with high activity for fatty acid epoxides.
68064 EH3 (ABHD9): the first member of a new epoxide hydrolase family with high activity for fatty acid epoxides.
68065 EH3 (ABHD9): the first member of a new epoxide hydrolase family with high activity for fatty acid epoxides.
68065 EH3 (ABHD9): the first member of a new epoxide hydrolase family with high activity for fatty acid epoxides.
68066 EH3 (ABHD9): the first member of a new epoxide hydrolase family with high activity for fatty acid epoxides.
68066 EH3 (ABHD9): the first member of a new epoxide hydrolase family with high activity for fatty acid epoxides.
68067 EH3 (ABHD9): the first member of a new epoxide hydrolase family with high activity for fatty acid epoxides.
68067 EH3 (ABHD9): the first member of a new epoxide hydrolase family with high activity for fatty acid epoxides.
68068 EH3 (ABHD9): the first member of a new epoxide hydrolase family with high activity for fatty acid epoxides.
68068 EH3 (ABHD9): the first member of a new epoxide hydrolase family with high activity for fatty acid epoxides.
68069 EH3 (ABHD9): the first member of a new epoxide hydrolase family with high activity for fatty acid epoxides.
68069 EH3 (ABHD9): the first member of a new epoxide hydrolase family with high activity for fatty acid epoxides.
68070 EH3 (ABHD9): the first member of a new epoxide hydrolase family with high activity for fatty acid epoxides.
68070 EH3 (ABHD9): the first member of a new epoxide hydrolase family with high activity for fatty acid epoxides.
68071 A methylaspartate cycle in haloarchaea.
68071 A methylaspartate cycle in haloarchaea.
68072 A methylaspartate cycle in haloarchaea.
68072 A methylaspartate cycle in haloarchaea.
68073 A methylaspartate cycle in haloarchaea.
68073 A methylaspartate cycle in haloarchaea.
68074 A methylaspartate cycle in haloarchaea.
68074 A methylaspartate cycle in haloarchaea.
68075 A methylaspartate cycle in haloarchaea.
68075 A methylaspartate cycle in haloarchaea.
68076 A methylaspartate cycle in haloarchaea.
68076 A methylaspartate cycle in haloarchaea.
68077 A methylaspartate cycle in haloarchaea.
68077 A methylaspartate cycle in haloarchaea.
68078 A methylaspartate cycle in haloarchaea.
68078 A methylaspartate cycle in haloarchaea.
68079 A methylaspartate cycle in haloarchaea.
68079 A methylaspartate cycle in haloarchaea.
68080 A methylaspartate cycle in haloarchaea.
68080 A methylaspartate cycle in haloarchaea.
68081 A methylaspartate cycle in haloarchaea.
68081 A methylaspartate cycle in haloarchaea.
68082 A methylaspartate cycle in haloarchaea.
68082 A methylaspartate cycle in haloarchaea.
68083 A methylaspartate cycle in haloarchaea.
68083 A methylaspartate cycle in haloarchaea.
68084 A genetic locus required for iron acquisition in Mycobacterium tuberculosis
68084 A genetic locus required for iron acquisition in Mycobacterium tuberculosis
68085 A genetic locus required for iron acquisition in Mycobacterium tuberculosis
68085 A genetic locus required for iron acquisition in Mycobacterium tuberculosis
68086 A genetic locus required for iron acquisition in Mycobacterium tuberculosis
68086 A genetic locus required for iron acquisition in Mycobacterium tuberculosis
68087 A genetic locus required for iron acquisition in Mycobacterium tuberculosis
68087 A genetic locus required for iron acquisition in Mycobacterium tuberculosis
68088 A genetic locus required for iron acquisition in Mycobacterium tuberculosis
68088 A genetic locus required for iron acquisition in Mycobacterium tuberculosis
68089 PapA1 and PapA2 are acyltransferases essential for the biosynthesis of the Mycobacterium tuberculosis ...
68089 PapA1 and PapA2 are acyltransferases essential for the biosynthesis of the Mycobacterium tuberculosis ...
68090 PapA1 and PapA2 are acyltransferases essential for the biosynthesis of the Mycobacterium tuberculosis ...
68090 PapA1 and PapA2 are acyltransferases essential for the biosynthesis of the Mycobacterium tuberculosis ...
68091 PapA1 and PapA2 are acyltransferases essential for the biosynthesis of the Mycobacterium tuberculosis ...
68091 PapA1 and PapA2 are acyltransferases essential for the biosynthesis of the Mycobacterium tuberculosis ...
68092 Purification and properties of NADP(+)-dependent isocitrate dehydrogenase from the corpus luteum
68092 Purification and properties of NADP(+)-dependent isocitrate dehydrogenase from the corpus luteum
68093 Purification and physicochemical characterization of chicken heart citrate synthase.
68093 Purification and physicochemical characterization of chicken heart citrate synthase.
68094 Escherichia coli citrate synthase. Purification and the effect of potassium on some properties.
68094 Escherichia coli citrate synthase. Purification and the effect of potassium on some properties.
68095 Escherichia coli citrate synthase. Purification and the effect of potassium on some properties.
68095 Escherichia coli citrate synthase. Purification and the effect of potassium on some properties.
68096 Kinetic studies on citrate synthase from pig heart.
68096 Kinetic studies on citrate synthase from pig heart.
68097 Studies on two isozymes of aconitase from Bacillus cereus T. III. Enzymatic properties.
68097 Studies on two isozymes of aconitase from Bacillus cereus T. III. Enzymatic properties.
68098 Studies on two isozymes of aconitase from Bacillus cereus T. III. Enzymatic properties.
68098 Studies on two isozymes of aconitase from Bacillus cereus T. III. Enzymatic properties.
68099 Studies on two isozymes of aconitase from Bacillus cereus T. III. Enzymatic properties.
68099 Studies on two isozymes of aconitase from Bacillus cereus T. III. Enzymatic properties.
68100 Studies on two isozymes of aconitase from Bacillus cereus T. III. Enzymatic properties.
68100 Studies on two isozymes of aconitase from Bacillus cereus T. III. Enzymatic properties.
68101 Evidence for the identity and some comparative properties of alpha-ketoglutarate and 2-keto-4-hydroxyglutarate ...
68101 Evidence for the identity and some comparative properties of alpha-ketoglutarate and 2-keto-4-hydroxyglutarate ...
68102 Evidence for the identity and some comparative properties of alpha-ketoglutarate and 2-keto-4-hydroxyglutarate ...
68102 Evidence for the identity and some comparative properties of alpha-ketoglutarate and 2-keto-4-hydroxyglutarate ...
68103 Evidence for the identity and some comparative properties of alpha-ketoglutarate and 2-keto-4-hydroxyglutarate ...
68103 Evidence for the identity and some comparative properties of alpha-ketoglutarate and 2-keto-4-hydroxyglutarate ...
68104 Evidence for the identity and some comparative properties of alpha-ketoglutarate and 2-keto-4-hydroxyglutarate ...
68104 Evidence for the identity and some comparative properties of alpha-ketoglutarate and 2-keto-4-hydroxyglutarate ...
68105 Evidence for the identity and some comparative properties of alpha-ketoglutarate and 2-keto-4-hydroxyglutarate ...
68105 Evidence for the identity and some comparative properties of alpha-ketoglutarate and 2-keto-4-hydroxyglutarate ...
68106 Evidence for the identity and some comparative properties of alpha-ketoglutarate and 2-keto-4-hydroxyglutarate ...
68106 Evidence for the identity and some comparative properties of alpha-ketoglutarate and 2-keto-4-hydroxyglutarate ...
68107 Evidence for the identity and some comparative properties of alpha-ketoglutarate and 2-keto-4-hydroxyglutarate ...
68107 Evidence for the identity and some comparative properties of alpha-ketoglutarate and 2-keto-4-hydroxyglutarate ...
68108 Evidence for the identity and some comparative properties of alpha-ketoglutarate and 2-keto-4-hydroxyglutarate ...
68108 Evidence for the identity and some comparative properties of alpha-ketoglutarate and 2-keto-4-hydroxyglutarate ...
68109 Purification and properties of NADP+:isocitrate dehydrogenase from lactating bovine mammary gland.
68109 Purification and properties of NADP+:isocitrate dehydrogenase from lactating bovine mammary gland.
68110 Purification and properties of NADP+:isocitrate dehydrogenase from lactating bovine mammary gland.
68110 Purification and properties of NADP+:isocitrate dehydrogenase from lactating bovine mammary gland.
68111 Purification and properties of NADP+:isocitrate dehydrogenase from lactating bovine mammary gland.
68111 Purification and properties of NADP+:isocitrate dehydrogenase from lactating bovine mammary gland.
68112 Purification and properties of NADP+:isocitrate dehydrogenase from lactating bovine mammary gland.
68112 Purification and properties of NADP+:isocitrate dehydrogenase from lactating bovine mammary gland.
68113 Purification and properties of NADP+:isocitrate dehydrogenase from lactating bovine mammary gland.
68113 Purification and properties of NADP+:isocitrate dehydrogenase from lactating bovine mammary gland.
68114 Biochemical characterization of dTDP-D-Qui4N and dTDP-D-Qui4NAc biosynthetic pathways in Shigella dysenteriae ...
68114 Biochemical characterization of dTDP-D-Qui4N and dTDP-D-Qui4NAc biosynthetic pathways in Shigella dysenteriae ...
68115 Biochemical characterization of dTDP-D-Qui4N and dTDP-D-Qui4NAc biosynthetic pathways in Shigella dysenteriae ...
68115 Biochemical characterization of dTDP-D-Qui4N and dTDP-D-Qui4NAc biosynthetic pathways in Shigella dysenteriae ...
68116 Biochemical characterization of dTDP-D-Qui4N and dTDP-D-Qui4NAc biosynthetic pathways in Shigella dysenteriae ...
68116 Biochemical characterization of dTDP-D-Qui4N and dTDP-D-Qui4NAc biosynthetic pathways in Shigella dysenteriae ...
68117 Biochemical characterization of dTDP-D-Qui4N and dTDP-D-Qui4NAc biosynthetic pathways in Shigella dysenteriae ...
68117 Biochemical characterization of dTDP-D-Qui4N and dTDP-D-Qui4NAc biosynthetic pathways in Shigella dysenteriae ...
68118 Inhibition of the Escherichia coli pyruvate dehydrogenase complex E1 subunit and its tyrosine 177 variants by ...
68118 Inhibition of the Escherichia coli pyruvate dehydrogenase complex E1 subunit and its tyrosine 177 variants by ...
68119 Inhibition of the Escherichia coli pyruvate dehydrogenase complex E1 subunit and its tyrosine 177 variants by ...
68119 Inhibition of the Escherichia coli pyruvate dehydrogenase complex E1 subunit and its tyrosine 177 variants by ...
68120 Inhibition of the Escherichia coli pyruvate dehydrogenase complex E1 subunit and its tyrosine 177 variants by ...
68120 Inhibition of the Escherichia coli pyruvate dehydrogenase complex E1 subunit and its tyrosine 177 variants by ...
68121 Inhibition of the Escherichia coli pyruvate dehydrogenase complex E1 subunit and its tyrosine 177 variants by ...
68121 Inhibition of the Escherichia coli pyruvate dehydrogenase complex E1 subunit and its tyrosine 177 variants by ...
68122 Inhibition of the Escherichia coli pyruvate dehydrogenase complex E1 subunit and its tyrosine 177 variants by ...
68122 Inhibition of the Escherichia coli pyruvate dehydrogenase complex E1 subunit and its tyrosine 177 variants by ...
68123 Inhibition of the Escherichia coli pyruvate dehydrogenase complex E1 subunit and its tyrosine 177 variants by ...
68123 Inhibition of the Escherichia coli pyruvate dehydrogenase complex E1 subunit and its tyrosine 177 variants by ...
68124 Inhibition of the Escherichia coli pyruvate dehydrogenase complex E1 subunit and its tyrosine 177 variants by ...
68124 Inhibition of the Escherichia coli pyruvate dehydrogenase complex E1 subunit and its tyrosine 177 variants by ...
68125 Inhibition of the Escherichia coli pyruvate dehydrogenase complex E1 subunit and its tyrosine 177 variants by ...
68125 Inhibition of the Escherichia coli pyruvate dehydrogenase complex E1 subunit and its tyrosine 177 variants by ...
68126 Inhibition of the Escherichia coli pyruvate dehydrogenase complex E1 subunit and its tyrosine 177 variants by ...
68126 Inhibition of the Escherichia coli pyruvate dehydrogenase complex E1 subunit and its tyrosine 177 variants by ...
68127 Inhibition of the Escherichia coli pyruvate dehydrogenase complex E1 subunit and its tyrosine 177 variants by ...
68127 Inhibition of the Escherichia coli pyruvate dehydrogenase complex E1 subunit and its tyrosine 177 variants by ...
68128 Inhibition of the Escherichia coli pyruvate dehydrogenase complex E1 subunit and its tyrosine 177 variants by ...
68128 Inhibition of the Escherichia coli pyruvate dehydrogenase complex E1 subunit and its tyrosine 177 variants by ...
68129 Inhibition of the Escherichia coli pyruvate dehydrogenase complex E1 subunit and its tyrosine 177 variants by ...
68129 Inhibition of the Escherichia coli pyruvate dehydrogenase complex E1 subunit and its tyrosine 177 variants by ...
68130 Inhibition of the Escherichia coli pyruvate dehydrogenase complex E1 subunit and its tyrosine 177 variants by ...
68130 Inhibition of the Escherichia coli pyruvate dehydrogenase complex E1 subunit and its tyrosine 177 variants by ...
68131 Inhibition of the Escherichia coli pyruvate dehydrogenase complex E1 subunit and its tyrosine 177 variants by ...
68131 Inhibition of the Escherichia coli pyruvate dehydrogenase complex E1 subunit and its tyrosine 177 variants by ...
68132 Inhibition of the Escherichia coli pyruvate dehydrogenase complex E1 subunit and its tyrosine 177 variants by ...
68132 Inhibition of the Escherichia coli pyruvate dehydrogenase complex E1 subunit and its tyrosine 177 variants by ...
68133 Inhibition of the Escherichia coli pyruvate dehydrogenase complex E1 subunit and its tyrosine 177 variants by ...
68133 Inhibition of the Escherichia coli pyruvate dehydrogenase complex E1 subunit and its tyrosine 177 variants by ...
68134 Inhibition of the Escherichia coli pyruvate dehydrogenase complex E1 subunit and its tyrosine 177 variants by ...
68134 Inhibition of the Escherichia coli pyruvate dehydrogenase complex E1 subunit and its tyrosine 177 variants by ...
68135 Inhibition of the Escherichia coli pyruvate dehydrogenase complex E1 subunit and its tyrosine 177 variants by ...
68135 Inhibition of the Escherichia coli pyruvate dehydrogenase complex E1 subunit and its tyrosine 177 variants by ...
68136 Inhibition of the Escherichia coli pyruvate dehydrogenase complex E1 subunit and its tyrosine 177 variants by ...
68136 Inhibition of the Escherichia coli pyruvate dehydrogenase complex E1 subunit and its tyrosine 177 variants by ...
68137 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68137 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68138 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68138 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68139 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68139 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68140 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68140 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68141 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68141 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68142 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68142 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68143 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68143 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68144 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68144 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68145 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68145 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68146 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68146 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68147 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68147 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68148 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68148 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68149 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68149 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68150 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68150 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68151 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68151 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68152 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68152 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68153 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68153 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68154 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68154 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68155 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68155 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68156 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68156 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68157 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68157 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68158 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68158 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68159 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68159 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68160 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68160 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68161 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68161 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68162 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68162 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68163 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68163 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68164 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68164 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68165 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68165 Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific ...
68166 ACTIVATION AND INHIBITION OF DPN-LINKED ISOCITRATE DEHYDROGENASE OF HEART BY CERTAIN NUCLEOTIDES.
68166 ACTIVATION AND INHIBITION OF DPN-LINKED ISOCITRATE DEHYDROGENASE OF HEART BY CERTAIN NUCLEOTIDES.
68167 ACTIVATION AND INHIBITION OF DPN-LINKED ISOCITRATE DEHYDROGENASE OF HEART BY CERTAIN NUCLEOTIDES.
68167 ACTIVATION AND INHIBITION OF DPN-LINKED ISOCITRATE DEHYDROGENASE OF HEART BY CERTAIN NUCLEOTIDES.
68168 ACTIVATION AND INHIBITION OF DPN-LINKED ISOCITRATE DEHYDROGENASE OF HEART BY CERTAIN NUCLEOTIDES.
68168 ACTIVATION AND INHIBITION OF DPN-LINKED ISOCITRATE DEHYDROGENASE OF HEART BY CERTAIN NUCLEOTIDES.
68169 ACTIVATION AND INHIBITION OF DPN-LINKED ISOCITRATE DEHYDROGENASE OF HEART BY CERTAIN NUCLEOTIDES.
68169 ACTIVATION AND INHIBITION OF DPN-LINKED ISOCITRATE DEHYDROGENASE OF HEART BY CERTAIN NUCLEOTIDES.
68170 ACTIVATION AND INHIBITION OF DPN-LINKED ISOCITRATE DEHYDROGENASE OF HEART BY CERTAIN NUCLEOTIDES.
68170 ACTIVATION AND INHIBITION OF DPN-LINKED ISOCITRATE DEHYDROGENASE OF HEART BY CERTAIN NUCLEOTIDES.
68171 ACTIVATION AND INHIBITION OF DPN-LINKED ISOCITRATE DEHYDROGENASE OF HEART BY CERTAIN NUCLEOTIDES.
68171 ACTIVATION AND INHIBITION OF DPN-LINKED ISOCITRATE DEHYDROGENASE OF HEART BY CERTAIN NUCLEOTIDES.
68172 ACTIVATION AND INHIBITION OF DPN-LINKED ISOCITRATE DEHYDROGENASE OF HEART BY CERTAIN NUCLEOTIDES.
68172 ACTIVATION AND INHIBITION OF DPN-LINKED ISOCITRATE DEHYDROGENASE OF HEART BY CERTAIN NUCLEOTIDES.
68173 ACTIVATION AND INHIBITION OF DPN-LINKED ISOCITRATE DEHYDROGENASE OF HEART BY CERTAIN NUCLEOTIDES.
68173 ACTIVATION AND INHIBITION OF DPN-LINKED ISOCITRATE DEHYDROGENASE OF HEART BY CERTAIN NUCLEOTIDES.
68174 ACTIVATION AND INHIBITION OF DPN-LINKED ISOCITRATE DEHYDROGENASE OF HEART BY CERTAIN NUCLEOTIDES.
68174 ACTIVATION AND INHIBITION OF DPN-LINKED ISOCITRATE DEHYDROGENASE OF HEART BY CERTAIN NUCLEOTIDES.
68175 ACTIVATION AND INHIBITION OF DPN-LINKED ISOCITRATE DEHYDROGENASE OF HEART BY CERTAIN NUCLEOTIDES.
68175 ACTIVATION AND INHIBITION OF DPN-LINKED ISOCITRATE DEHYDROGENASE OF HEART BY CERTAIN NUCLEOTIDES.
68176 ACTIVATION AND INHIBITION OF DPN-LINKED ISOCITRATE DEHYDROGENASE OF HEART BY CERTAIN NUCLEOTIDES.
68176 ACTIVATION AND INHIBITION OF DPN-LINKED ISOCITRATE DEHYDROGENASE OF HEART BY CERTAIN NUCLEOTIDES.
68177 ACTIVATION AND INHIBITION OF DPN-LINKED ISOCITRATE DEHYDROGENASE OF HEART BY CERTAIN NUCLEOTIDES.
68177 ACTIVATION AND INHIBITION OF DPN-LINKED ISOCITRATE DEHYDROGENASE OF HEART BY CERTAIN NUCLEOTIDES.
68178 ACTIVATION AND INHIBITION OF DPN-LINKED ISOCITRATE DEHYDROGENASE OF HEART BY CERTAIN NUCLEOTIDES.
68178 ACTIVATION AND INHIBITION OF DPN-LINKED ISOCITRATE DEHYDROGENASE OF HEART BY CERTAIN NUCLEOTIDES.
68179 ACTIVATION AND INHIBITION OF DPN-LINKED ISOCITRATE DEHYDROGENASE OF HEART BY CERTAIN NUCLEOTIDES.
68179 ACTIVATION AND INHIBITION OF DPN-LINKED ISOCITRATE DEHYDROGENASE OF HEART BY CERTAIN NUCLEOTIDES.
68180 ACTIVATION AND INHIBITION OF DPN-LINKED ISOCITRATE DEHYDROGENASE OF HEART BY CERTAIN NUCLEOTIDES.
68180 ACTIVATION AND INHIBITION OF DPN-LINKED ISOCITRATE DEHYDROGENASE OF HEART BY CERTAIN NUCLEOTIDES.
68181 ACTIVATION AND INHIBITION OF DPN-LINKED ISOCITRATE DEHYDROGENASE OF HEART BY CERTAIN NUCLEOTIDES.
68181 ACTIVATION AND INHIBITION OF DPN-LINKED ISOCITRATE DEHYDROGENASE OF HEART BY CERTAIN NUCLEOTIDES.
68182 Structure of human dCK suggests strategies to improve anticancer and antiviral therapy
68182 Structure of human dCK suggests strategies to improve anticancer and antiviral therapy
68183 Structure of human dCK suggests strategies to improve anticancer and antiviral therapy
68183 Structure of human dCK suggests strategies to improve anticancer and antiviral therapy
68184 Structure of human dCK suggests strategies to improve anticancer and antiviral therapy
68184 Structure of human dCK suggests strategies to improve anticancer and antiviral therapy
68185 Structure of human dCK suggests strategies to improve anticancer and antiviral therapy
68185 Structure of human dCK suggests strategies to improve anticancer and antiviral therapy
68186 Structure of human dCK suggests strategies to improve anticancer and antiviral therapy
68186 Structure of human dCK suggests strategies to improve anticancer and antiviral therapy
68187 Structure of human dCK suggests strategies to improve anticancer and antiviral therapy
68187 Structure of human dCK suggests strategies to improve anticancer and antiviral therapy
68188 Structure of human dCK suggests strategies to improve anticancer and antiviral therapy
68188 Structure of human dCK suggests strategies to improve anticancer and antiviral therapy
68189 Structure of human dCK suggests strategies to improve anticancer and antiviral therapy
68189 Structure of human dCK suggests strategies to improve anticancer and antiviral therapy
68190 Characterization of two kinases involved in thiamine pyrophosphate and pyridoxal phosphate biosynthesis in ...
68190 Characterization of two kinases involved in thiamine pyrophosphate and pyridoxal phosphate biosynthesis in ...
68191 Characterization of two kinases involved in thiamine pyrophosphate and pyridoxal phosphate biosynthesis in ...
68191 Characterization of two kinases involved in thiamine pyrophosphate and pyridoxal phosphate biosynthesis in ...
68192 Isolation and characterization of two fructokinase cDNA clones from rice
68192 Isolation and characterization of two fructokinase cDNA clones from rice
68193 Isolation and characterization of two fructokinase cDNA clones from rice
68193 Isolation and characterization of two fructokinase cDNA clones from rice
68194 Dynamically-driven enhancement of the catalytic machinery of the SARS 3C-like protease by the S284-T285-I286/A ...
68194 Dynamically-driven enhancement of the catalytic machinery of the SARS 3C-like protease by the S284-T285-I286/A ...
68195 Dynamically-driven enhancement of the catalytic machinery of the SARS 3C-like protease by the S284-T285-I286/A ...
68195 Dynamically-driven enhancement of the catalytic machinery of the SARS 3C-like protease by the S284-T285-I286/A ...
68196 Peptide aldehyde inhibitors challenge the substrate specificity of the SARS- coronavirus main protease
68196 Peptide aldehyde inhibitors challenge the substrate specificity of the SARS- coronavirus main protease
68197 Peptide aldehyde inhibitors challenge the substrate specificity of the SARS- coronavirus main protease
68197 Peptide aldehyde inhibitors challenge the substrate specificity of the SARS- coronavirus main protease
68198 Peptide aldehyde inhibitors challenge the substrate specificity of the SARS- coronavirus main protease
68198 Peptide aldehyde inhibitors challenge the substrate specificity of the SARS- coronavirus main protease
68199 Peptide aldehyde inhibitors challenge the substrate specificity of the SARS- coronavirus main protease
68199 Peptide aldehyde inhibitors challenge the substrate specificity of the SARS- coronavirus main protease
68200 Peptide aldehyde inhibitors challenge the substrate specificity of the SARS- coronavirus main protease
68200 Peptide aldehyde inhibitors challenge the substrate specificity of the SARS- coronavirus main protease
68201 Peptide aldehyde inhibitors challenge the substrate specificity of the SARS- coronavirus main protease
68201 Peptide aldehyde inhibitors challenge the substrate specificity of the SARS- coronavirus main protease
68202 Peptide aldehyde inhibitors challenge the substrate specificity of the SARS- coronavirus main protease
68202 Peptide aldehyde inhibitors challenge the substrate specificity of the SARS- coronavirus main protease
68203 Evidence that feedback inhibition of NAD kinase controls responses to oxidative stress
68203 Evidence that feedback inhibition of NAD kinase controls responses to oxidative stress
68204 Evidence that feedback inhibition of NAD kinase controls responses to oxidative stress
68204 Evidence that feedback inhibition of NAD kinase controls responses to oxidative stress
68205 Evidence that feedback inhibition of NAD kinase controls responses to oxidative stress
68205 Evidence that feedback inhibition of NAD kinase controls responses to oxidative stress
68206 Evidence that feedback inhibition of NAD kinase controls responses to oxidative stress
68206 Evidence that feedback inhibition of NAD kinase controls responses to oxidative stress
68207 Evidence that feedback inhibition of NAD kinase controls responses to oxidative stress
68207 Evidence that feedback inhibition of NAD kinase controls responses to oxidative stress
68208 Evidence that feedback inhibition of NAD kinase controls responses to oxidative stress
68208 Evidence that feedback inhibition of NAD kinase controls responses to oxidative stress
68209 Severe acute respiratory syndrome coronavirus papain-like novel protease inhibitors: design, synthesis, ...
68209 Severe acute respiratory syndrome coronavirus papain-like novel protease inhibitors: design, synthesis, ...
68210 Severe acute respiratory syndrome coronavirus papain-like novel protease inhibitors: design, synthesis, ...
68210 Severe acute respiratory syndrome coronavirus papain-like novel protease inhibitors: design, synthesis, ...
68211 Severe acute respiratory syndrome coronavirus papain-like novel protease inhibitors: design, synthesis, ...
68211 Severe acute respiratory syndrome coronavirus papain-like novel protease inhibitors: design, synthesis, ...
68212 Severe acute respiratory syndrome coronavirus papain-like novel protease inhibitors: design, synthesis, ...
68212 Severe acute respiratory syndrome coronavirus papain-like novel protease inhibitors: design, synthesis, ...
68213 Severe acute respiratory syndrome coronavirus papain-like novel protease inhibitors: design, synthesis, ...
68213 Severe acute respiratory syndrome coronavirus papain-like novel protease inhibitors: design, synthesis, ...
68214 Severe acute respiratory syndrome coronavirus papain-like novel protease inhibitors: design, synthesis, ...
68214 Severe acute respiratory syndrome coronavirus papain-like novel protease inhibitors: design, synthesis, ...
68215 Severe acute respiratory syndrome coronavirus papain-like novel protease inhibitors: design, synthesis, ...
68215 Severe acute respiratory syndrome coronavirus papain-like novel protease inhibitors: design, synthesis, ...
68216 Severe acute respiratory syndrome coronavirus papain-like novel protease inhibitors: design, synthesis, ...
68216 Severe acute respiratory syndrome coronavirus papain-like novel protease inhibitors: design, synthesis, ...
68217 Severe acute respiratory syndrome coronavirus papain-like novel protease inhibitors: design, synthesis, ...
68217 Severe acute respiratory syndrome coronavirus papain-like novel protease inhibitors: design, synthesis, ...
68218 Severe acute respiratory syndrome coronavirus papain-like novel protease inhibitors: design, synthesis, ...
68218 Severe acute respiratory syndrome coronavirus papain-like novel protease inhibitors: design, synthesis, ...
68219 Severe acute respiratory syndrome coronavirus papain-like novel protease inhibitors: design, synthesis, ...
68219 Severe acute respiratory syndrome coronavirus papain-like novel protease inhibitors: design, synthesis, ...
68220 Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors ...
68220 Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors ...
68221 Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors ...
68221 Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors ...
68222 Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors ...
68222 Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors ...
68223 Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors ...
68223 Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors ...
68224 Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors ...
68224 Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors ...
68225 Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors ...
68225 Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors ...
68226 Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors ...
68226 Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors ...
68227 Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors ...
68227 Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors ...
68228 Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors ...
68228 Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors ...
68229 Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors ...
68229 Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors ...
68230 Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors ...
68230 Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors ...
68231 Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors ...
68231 Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors ...
68232 Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors ...
68232 Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors ...
68233 Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors ...
68233 Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors ...
68234 Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors ...
68234 Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors ...
68235 Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors ...
68235 Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors ...
68236 Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors ...
68236 Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors ...
68237 Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors ...
68237 Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors ...
68238 Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors ...
68238 Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors ...
68239 Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors ...
68239 Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors ...
68240 A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication
68240 A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication
68241 A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication
68241 A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication
68242 A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication
68242 A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication
68243 A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication
68243 A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication
68244 A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication
68244 A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication
68245 A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication
68245 A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication
68246 A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication
68246 A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication
68247 A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication
68247 A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication
68248 Glycerol-insensitive Arabidopsis mutants: gli1 seedlings lack glycerol kinase, accumulate glycerol and are ...
68248 Glycerol-insensitive Arabidopsis mutants: gli1 seedlings lack glycerol kinase, accumulate glycerol and are ...
68249 Characterization of the 2'-5'-oligoadenylate synthetase ubiquitin-like family.
68249 Characterization of the 2'-5'-oligoadenylate synthetase ubiquitin-like family.
68250 Characterization of the 2'-5'-oligoadenylate synthetase ubiquitin-like family.
68250 Characterization of the 2'-5'-oligoadenylate synthetase ubiquitin-like family.
68251 Characterization of the 2'-5'-oligoadenylate synthetase ubiquitin-like family.
68251 Characterization of the 2'-5'-oligoadenylate synthetase ubiquitin-like family.
68252 Characterization of the 2'-5'-oligoadenylate synthetase ubiquitin-like family.
68252 Characterization of the 2'-5'-oligoadenylate synthetase ubiquitin-like family.
68253 Characterization of the 2'-5'-oligoadenylate synthetase ubiquitin-like family.
68253 Characterization of the 2'-5'-oligoadenylate synthetase ubiquitin-like family.
68254 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68254 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68255 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68255 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68256 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68256 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68257 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68257 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68258 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68258 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68259 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68259 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68260 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68260 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68261 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68261 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68262 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68262 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68263 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68263 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68264 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68264 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68265 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68265 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68266 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68266 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68267 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68267 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68268 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68268 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68269 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68269 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68270 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68270 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68271 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68271 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68272 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68272 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68273 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68273 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68274 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68274 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68275 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68275 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68276 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68276 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68277 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68277 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68278 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68278 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68279 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68279 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68280 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68280 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68281 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68281 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68282 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68282 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68283 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68283 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68284 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68284 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68285 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68285 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68286 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68286 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68287 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68287 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68288 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68288 X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human ...
68289 Identification and characterization of human ethanolaminephosphotransferase1
68289 Identification and characterization of human ethanolaminephosphotransferase1
68290 Phosphoenolpyruvate synthetase from the hyperthermophilic archaeon Pyrococcus furiosus
68290 Phosphoenolpyruvate synthetase from the hyperthermophilic archaeon Pyrococcus furiosus
68291 Phosphoenolpyruvate synthetase from the hyperthermophilic archaeon Pyrococcus furiosus
68291 Phosphoenolpyruvate synthetase from the hyperthermophilic archaeon Pyrococcus furiosus
68292 Phosphoenolpyruvate synthetase from the hyperthermophilic archaeon Pyrococcus furiosus
68292 Phosphoenolpyruvate synthetase from the hyperthermophilic archaeon Pyrococcus furiosus
68293 Phosphoenolpyruvate synthetase from the hyperthermophilic archaeon Pyrococcus furiosus
68293 Phosphoenolpyruvate synthetase from the hyperthermophilic archaeon Pyrococcus furiosus
68294 Phosphoenolpyruvate synthetase from the hyperthermophilic archaeon Pyrococcus furiosus
68294 Phosphoenolpyruvate synthetase from the hyperthermophilic archaeon Pyrococcus furiosus
68295 Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual ...
68295 Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual ...
68296 Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual ...
68296 Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual ...
68297 Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual ...
68297 Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual ...
68298 Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual ...
68298 Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual ...
68299 Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual ...
68299 Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual ...
68300 Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual ...
68300 Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual ...
68301 Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual ...
68301 Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual ...
68302 Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual ...
68302 Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual ...
68303 Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual ...
68303 Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual ...
68304 Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual ...
68304 Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual ...
68305 Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual ...
68305 Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual ...
68306 Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual ...
68306 Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual ...
68307 Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual ...
68307 Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual ...
68308 Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual ...
68308 Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual ...
68309 Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual ...
68309 Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual ...
68310 Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual ...
68310 Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual ...
68311 Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual ...
68311 Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual ...
68312 Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual ...
68312 Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual ...
68313 Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV. Version 3
68313 Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV. Version 3
68314 Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV. Version 3
68314 Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV. Version 3
68315 Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV. Version 3
68315 Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV. Version 3
68316 Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV. Version 3
68316 Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV. Version 3
68317 Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV. Version 3
68317 Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV. Version 3
68318 Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV. Version 3
68318 Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV. Version 3
68319 Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV. Version 3
68319 Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV. Version 3
68320 Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV. Version 3
68320 Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV. Version 3
68321 Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV. Version 3
68321 Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV. Version 3
68322 Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV. Version 3
68322 Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV. Version 3
68323 Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV. Version 3
68323 Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV. Version 3
68324 Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV. Version 3
68324 Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV. Version 3
68325 Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV. Version 3
68325 Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV. Version 3
68326 Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV. Version 3
68326 Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV. Version 3
68327 Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV. Version 3
68327 Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV. Version 3
68328 Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV. Version 3
68328 Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV. Version 3
68329 Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV. Version 3
68329 Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV. Version 3
68330 Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV. Version 3
68330 Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV. Version 3
68331 Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV. Version 3
68331 Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV. Version 3
68332 Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via ...
68332 Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via ...
68333 Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via ...
68333 Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via ...
68334 Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via ...
68334 Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via ...
68335 Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via ...
68335 Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via ...
68336 Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via ...
68336 Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via ...
68337 Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via ...
68337 Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via ...
68338 Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via ...
68338 Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via ...
68339 Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via ...
68339 Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via ...
68340 Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via ...
68340 Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via ...
68341 Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via ...
68341 Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via ...
68342 Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via ...
68342 Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via ...
68343 Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via ...
68343 Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via ...
68344 Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via ...
68344 Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via ...
68345 Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via ...
68345 Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via ...
68346 Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via ...
68346 Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via ...
68347 Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via ...
68347 Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via ...
68348 Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via ...
68348 Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via ...
68349 Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via ...
68349 Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via ...
68350 Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia ...
68350 Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia ...
68351 Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia ...
68351 Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia ...
68352 Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia ...
68352 Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia ...
68353 Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia ...
68353 Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia ...
68354 Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia ...
68354 Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia ...
68355 Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia ...
68355 Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia ...
68356 Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia ...
68356 Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia ...
68357 Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia ...
68357 Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia ...
68358 Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia ...
68358 Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia ...
68359 Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia ...
68359 Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia ...
68360 Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia ...
68360 Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia ...
68361 Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia ...
68361 Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia ...
68362 Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia ...
68362 Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia ...
68363 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68363 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68364 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68364 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68365 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68365 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68366 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68366 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68367 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68367 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68368 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68368 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68369 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68369 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68370 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68370 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68371 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68371 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68372 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68372 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68373 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68373 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68374 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68374 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68375 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68375 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68376 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68376 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68377 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68377 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68378 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68378 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68379 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68379 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68380 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68380 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68381 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68381 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68382 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68382 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68383 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68383 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68384 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68384 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68385 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68385 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68386 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68386 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68387 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68387 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68388 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68388 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68389 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68389 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68390 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68390 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68391 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68391 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68392 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68392 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68393 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68393 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68394 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68394 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68395 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68395 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68396 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68396 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68397 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68397 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68398 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68398 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68399 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68399 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68400 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68400 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68401 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68401 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68402 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68402 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68403 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68403 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68404 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68404 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68405 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68405 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68406 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68406 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68407 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68407 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68408 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68408 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68409 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68409 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68410 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68410 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68411 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68411 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68412 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68412 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68413 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68413 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68414 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68414 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68415 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68415 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68416 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68416 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68417 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68417 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68418 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68418 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68419 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68419 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68420 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68420 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68421 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68421 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68422 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68422 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68423 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68423 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68424 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68424 α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, ...
68425 Synthetic capacity of Arabidopsis phosphatidylinositol synthase 1 expressed in Escherichia coli
68425 Synthetic capacity of Arabidopsis phosphatidylinositol synthase 1 expressed in Escherichia coli
68426 Synthetic capacity of Arabidopsis phosphatidylinositol synthase 1 expressed in Escherichia coli
68426 Synthetic capacity of Arabidopsis phosphatidylinositol synthase 1 expressed in Escherichia coli
68427 Synthetic capacity of Arabidopsis phosphatidylinositol synthase 1 expressed in Escherichia coli
68427 Synthetic capacity of Arabidopsis phosphatidylinositol synthase 1 expressed in Escherichia coli
68428 Repression of Escherichia coli PhoP-PhoQ signaling by acetate reveals a regulatory role for acetyl coenzyme A
68428 Repression of Escherichia coli PhoP-PhoQ signaling by acetate reveals a regulatory role for acetyl coenzyme A
68429 Repression of Escherichia coli PhoP-PhoQ signaling by acetate reveals a regulatory role for acetyl coenzyme A
68429 Repression of Escherichia coli PhoP-PhoQ signaling by acetate reveals a regulatory role for acetyl coenzyme A
68430 Repression of Escherichia coli PhoP-PhoQ signaling by acetate reveals a regulatory role for acetyl coenzyme A
68430 Repression of Escherichia coli PhoP-PhoQ signaling by acetate reveals a regulatory role for acetyl coenzyme A
68431 Repression of Escherichia coli PhoP-PhoQ signaling by acetate reveals a regulatory role for acetyl coenzyme A
68431 Repression of Escherichia coli PhoP-PhoQ signaling by acetate reveals a regulatory role for acetyl coenzyme A
68432 Saturation mutagenesis reveals that GLU54 of norovirus 3C-like protease is not essential for the proteolytic ...
68432 Saturation mutagenesis reveals that GLU54 of norovirus 3C-like protease is not essential for the proteolytic ...
68433 Saturation mutagenesis reveals that GLU54 of norovirus 3C-like protease is not essential for the proteolytic ...
68433 Saturation mutagenesis reveals that GLU54 of norovirus 3C-like protease is not essential for the proteolytic ...
68434 Saturation mutagenesis reveals that GLU54 of norovirus 3C-like protease is not essential for the proteolytic ...
68434 Saturation mutagenesis reveals that GLU54 of norovirus 3C-like protease is not essential for the proteolytic ...
68435 Saturation mutagenesis reveals that GLU54 of norovirus 3C-like protease is not essential for the proteolytic ...
68435 Saturation mutagenesis reveals that GLU54 of norovirus 3C-like protease is not essential for the proteolytic ...
68436 Saturation mutagenesis reveals that GLU54 of norovirus 3C-like protease is not essential for the proteolytic ...
68436 Saturation mutagenesis reveals that GLU54 of norovirus 3C-like protease is not essential for the proteolytic ...
68437 Saturation mutagenesis reveals that GLU54 of norovirus 3C-like protease is not essential for the proteolytic ...
68437 Saturation mutagenesis reveals that GLU54 of norovirus 3C-like protease is not essential for the proteolytic ...
68438 Saturation mutagenesis reveals that GLU54 of norovirus 3C-like protease is not essential for the proteolytic ...
68438 Saturation mutagenesis reveals that GLU54 of norovirus 3C-like protease is not essential for the proteolytic ...
68439 Saturation mutagenesis reveals that GLU54 of norovirus 3C-like protease is not essential for the proteolytic ...
68439 Saturation mutagenesis reveals that GLU54 of norovirus 3C-like protease is not essential for the proteolytic ...
68440 Saturation mutagenesis reveals that GLU54 of norovirus 3C-like protease is not essential for the proteolytic ...
68440 Saturation mutagenesis reveals that GLU54 of norovirus 3C-like protease is not essential for the proteolytic ...
68441 Saturation mutagenesis reveals that GLU54 of norovirus 3C-like protease is not essential for the proteolytic ...
68441 Saturation mutagenesis reveals that GLU54 of norovirus 3C-like protease is not essential for the proteolytic ...
68442 Saturation mutagenesis reveals that GLU54 of norovirus 3C-like protease is not essential for the proteolytic ...
68442 Saturation mutagenesis reveals that GLU54 of norovirus 3C-like protease is not essential for the proteolytic ...
68443 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68443 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68444 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68444 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68445 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68445 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68446 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68446 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68447 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68447 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68448 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68448 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68449 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68449 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68450 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68450 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68451 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68451 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68452 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68452 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68453 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68453 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68454 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68454 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68455 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68455 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68456 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68456 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68457 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68457 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68458 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68458 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68459 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68459 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68460 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68460 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68461 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68461 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68462 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68462 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68463 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68463 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68464 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68464 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68465 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68465 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68466 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68466 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68467 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68467 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68468 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68468 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68469 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68469 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68470 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68470 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68471 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68471 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68472 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68472 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68473 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68473 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68474 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68474 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68475 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68475 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68476 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68476 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68477 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68477 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68478 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68478 Two NAD+-isocitrate dehydrogenase forms in Phycomyces blakesleeanus. Induction in response to acetate growth ...
68479 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68479 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68480 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68480 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68481 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68481 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68482 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68482 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68483 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68483 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68484 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68484 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68485 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68485 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68486 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68486 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68487 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68487 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68488 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68488 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68489 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68489 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68490 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68490 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68491 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68491 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68492 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68492 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68493 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68493 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68494 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68494 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68495 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68495 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68496 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68496 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68497 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68497 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68498 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68498 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68499 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68499 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68500 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68500 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68501 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68501 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68502 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68502 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68503 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68503 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68504 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68504 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68505 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68505 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68506 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68506 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68507 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68507 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68508 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68508 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68509 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68509 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68510 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68510 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68511 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68511 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68512 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68512 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68513 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68513 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
68514 Regulation of glutamate metabolism by protein kinases in mycobacteria.
68514 Regulation of glutamate metabolism by protein kinases in mycobacteria.
68515 Regulation of glutamate metabolism by protein kinases in mycobacteria.
68515 Regulation of glutamate metabolism by protein kinases in mycobacteria.
68516 Regulation of glutamate metabolism by protein kinases in mycobacteria.
68516 Regulation of glutamate metabolism by protein kinases in mycobacteria.
68517 Regulation of glutamate metabolism by protein kinases in mycobacteria.
68517 Regulation of glutamate metabolism by protein kinases in mycobacteria.
68518 Regulation of glutamate metabolism by protein kinases in mycobacteria.
68518 Regulation of glutamate metabolism by protein kinases in mycobacteria.
68519 Two different dihydroorotate dehydrogenases from yeast Saccharomyces kluyveri
68519 Two different dihydroorotate dehydrogenases from yeast Saccharomyces kluyveri
68520 Two different dihydroorotate dehydrogenases from yeast Saccharomyces kluyveri
68520 Two different dihydroorotate dehydrogenases from yeast Saccharomyces kluyveri
68521 Two different dihydroorotate dehydrogenases from yeast Saccharomyces kluyveri
68521 Two different dihydroorotate dehydrogenases from yeast Saccharomyces kluyveri
68522 Two different dihydroorotate dehydrogenases from yeast Saccharomyces kluyveri
68522 Two different dihydroorotate dehydrogenases from yeast Saccharomyces kluyveri
68523 Two different dihydroorotate dehydrogenases from yeast Saccharomyces kluyveri
68523 Two different dihydroorotate dehydrogenases from yeast Saccharomyces kluyveri
68524 Two different dihydroorotate dehydrogenases from yeast Saccharomyces kluyveri
68524 Two different dihydroorotate dehydrogenases from yeast Saccharomyces kluyveri
68525 Two different dihydroorotate dehydrogenases from yeast Saccharomyces kluyveri
68525 Two different dihydroorotate dehydrogenases from yeast Saccharomyces kluyveri
68526 Two different dihydroorotate dehydrogenases from yeast Saccharomyces kluyveri
68526 Two different dihydroorotate dehydrogenases from yeast Saccharomyces kluyveri
68527 Two different dihydroorotate dehydrogenases from yeast Saccharomyces kluyveri
68527 Two different dihydroorotate dehydrogenases from yeast Saccharomyces kluyveri
68528 Two different dihydroorotate dehydrogenases from yeast Saccharomyces kluyveri
68528 Two different dihydroorotate dehydrogenases from yeast Saccharomyces kluyveri
68529 Two different dihydroorotate dehydrogenases from yeast Saccharomyces kluyveri
68529 Two different dihydroorotate dehydrogenases from yeast Saccharomyces kluyveri
68530 Two different dihydroorotate dehydrogenases from yeast Saccharomyces kluyveri
68530 Two different dihydroorotate dehydrogenases from yeast Saccharomyces kluyveri
68531 Two different dihydroorotate dehydrogenases from yeast Saccharomyces kluyveri
68531 Two different dihydroorotate dehydrogenases from yeast Saccharomyces kluyveri
68532 Two different dihydroorotate dehydrogenases from yeast Saccharomyces kluyveri
68532 Two different dihydroorotate dehydrogenases from yeast Saccharomyces kluyveri
68533 Purification and biochemical characterization of a hydroxyneurosporene desaturase involved in the biosynthetic ...
68533 Purification and biochemical characterization of a hydroxyneurosporene desaturase involved in the biosynthetic ...
68534 The obligate intracellular parasite Toxoplasma gondii secretes a soluble phosphatidylserine decarboxylase
68534 The obligate intracellular parasite Toxoplasma gondii secretes a soluble phosphatidylserine decarboxylase
68535 Structural study reveals that Ser-354 determines substrate specificity on human histidine decarboxylase
68535 Structural study reveals that Ser-354 determines substrate specificity on human histidine decarboxylase
68536 Structural study reveals that Ser-354 determines substrate specificity on human histidine decarboxylase
68536 Structural study reveals that Ser-354 determines substrate specificity on human histidine decarboxylase
68537 Structural study reveals that Ser-354 determines substrate specificity on human histidine decarboxylase
68537 Structural study reveals that Ser-354 determines substrate specificity on human histidine decarboxylase
68538 Structural study reveals that Ser-354 determines substrate specificity on human histidine decarboxylase
68538 Structural study reveals that Ser-354 determines substrate specificity on human histidine decarboxylase
68539 Structural study reveals that Ser-354 determines substrate specificity on human histidine decarboxylase
68539 Structural study reveals that Ser-354 determines substrate specificity on human histidine decarboxylase
68540 An alternative polyamine biosynthetic pathway is widespread in bacteria and essential for biofilm formation in ...
68540 An alternative polyamine biosynthetic pathway is widespread in bacteria and essential for biofilm formation in ...
68541 An alternative polyamine biosynthetic pathway is widespread in bacteria and essential for biofilm formation in ...
68541 An alternative polyamine biosynthetic pathway is widespread in bacteria and essential for biofilm formation in ...
68542 An alternative polyamine biosynthetic pathway is widespread in bacteria and essential for biofilm formation in ...
68542 An alternative polyamine biosynthetic pathway is widespread in bacteria and essential for biofilm formation in ...
68543 An alternative polyamine biosynthetic pathway is widespread in bacteria and essential for biofilm formation in ...
68543 An alternative polyamine biosynthetic pathway is widespread in bacteria and essential for biofilm formation in ...
68544 Ethylmalonyl-CoA decarboxylase, a new enzyme involved in metabolite proofreading
68544 Ethylmalonyl-CoA decarboxylase, a new enzyme involved in metabolite proofreading
68545 Ethylmalonyl-CoA decarboxylase, a new enzyme involved in metabolite proofreading
68545 Ethylmalonyl-CoA decarboxylase, a new enzyme involved in metabolite proofreading
68546 Ethylmalonyl-CoA decarboxylase, a new enzyme involved in metabolite proofreading
68546 Ethylmalonyl-CoA decarboxylase, a new enzyme involved in metabolite proofreading
68547 Ethylmalonyl-CoA decarboxylase, a new enzyme involved in metabolite proofreading
68547 Ethylmalonyl-CoA decarboxylase, a new enzyme involved in metabolite proofreading
68548 Structure of Main Protease from Human Coronavirus NL63: Insights for Wide Spectrum Anti-Coronavirus Drug ...
68548 Structure of Main Protease from Human Coronavirus NL63: Insights for Wide Spectrum Anti-Coronavirus Drug ...
68549 Structure of Main Protease from Human Coronavirus NL63: Insights for Wide Spectrum Anti-Coronavirus Drug ...
68549 Structure of Main Protease from Human Coronavirus NL63: Insights for Wide Spectrum Anti-Coronavirus Drug ...
68550 Production of authentic SARS-CoV M(pro) with enhanced activity: application as a novel tag-cleavage ...
68550 Production of authentic SARS-CoV M(pro) with enhanced activity: application as a novel tag-cleavage ...
68551 Production of authentic SARS-CoV M(pro) with enhanced activity: application as a novel tag-cleavage ...
68551 Production of authentic SARS-CoV M(pro) with enhanced activity: application as a novel tag-cleavage ...
68552 Production of authentic SARS-CoV M(pro) with enhanced activity: application as a novel tag-cleavage ...
68552 Production of authentic SARS-CoV M(pro) with enhanced activity: application as a novel tag-cleavage ...
68553 Production of authentic SARS-CoV M(pro) with enhanced activity: application as a novel tag-cleavage ...
68553 Production of authentic SARS-CoV M(pro) with enhanced activity: application as a novel tag-cleavage ...
68554 Production of authentic SARS-CoV M(pro) with enhanced activity: application as a novel tag-cleavage ...
68554 Production of authentic SARS-CoV M(pro) with enhanced activity: application as a novel tag-cleavage ...
68555 Production of authentic SARS-CoV M(pro) with enhanced activity: application as a novel tag-cleavage ...
68555 Production of authentic SARS-CoV M(pro) with enhanced activity: application as a novel tag-cleavage ...
68556 Role of glutamate decarboxylase-like protein 1 (GADL1) in taurine biosynthesis
68556 Role of glutamate decarboxylase-like protein 1 (GADL1) in taurine biosynthesis
68557 Role of glutamate decarboxylase-like protein 1 (GADL1) in taurine biosynthesis
68557 Role of glutamate decarboxylase-like protein 1 (GADL1) in taurine biosynthesis
68558 Identification and characterization of a re-citrate synthase in Dehalococcoides strain CBDB1
68558 Identification and characterization of a re-citrate synthase in Dehalococcoides strain CBDB1
68559 Identification and characterization of a re-citrate synthase in Dehalococcoides strain CBDB1
68559 Identification and characterization of a re-citrate synthase in Dehalococcoides strain CBDB1
68560 Purification in an active state and properties of the 3-step phytoene desaturase from Rhodobacter capsulatus ...
68560 Purification in an active state and properties of the 3-step phytoene desaturase from Rhodobacter capsulatus ...
68561 Purification in an active state and properties of the 3-step phytoene desaturase from Rhodobacter capsulatus ...
68561 Purification in an active state and properties of the 3-step phytoene desaturase from Rhodobacter capsulatus ...
68562 Purification in an active state and properties of the 3-step phytoene desaturase from Rhodobacter capsulatus ...
68562 Purification in an active state and properties of the 3-step phytoene desaturase from Rhodobacter capsulatus ...
68563 Purification in an active state and properties of the 3-step phytoene desaturase from Rhodobacter capsulatus ...
68563 Purification in an active state and properties of the 3-step phytoene desaturase from Rhodobacter capsulatus ...
68564 Phytoene desaturase: heterologous expression in an active state, purification, and biochemical properties
68564 Phytoene desaturase: heterologous expression in an active state, purification, and biochemical properties
68565 Phytoene desaturase: heterologous expression in an active state, purification, and biochemical properties
68565 Phytoene desaturase: heterologous expression in an active state, purification, and biochemical properties
68566 Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of ...
68566 Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of ...
68567 Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of ...
68567 Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of ...
68568 Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of ...
68568 Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of ...
68569 Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of ...
68569 Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of ...
68570 Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of ...
68570 Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of ...
68571 Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of ...
68571 Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of ...
68572 Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of ...
68572 Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of ...
68573 Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of ...
68573 Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of ...
68574 Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of ...
68574 Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of ...
68575 Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of ...
68575 Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of ...
68576 Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of ...
68576 Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of ...
68577 Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of ...
68577 Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of ...
68578 Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of ...
68578 Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of ...
68579 Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of ...
68579 Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of ...
68580 Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of ...
68580 Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of ...
68581 Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of ...
68581 Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of ...
68582 Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of ...
68582 Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of ...
68583 Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of ...
68583 Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of ...
68584 Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of ...
68584 Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of ...
68585 Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of ...
68585 Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of ...
68586 Mouse steroid sulfotransferases: substrate specificity and preliminary X-ray crystallographic analysis
68586 Mouse steroid sulfotransferases: substrate specificity and preliminary X-ray crystallographic analysis
68587 Mouse steroid sulfotransferases: substrate specificity and preliminary X-ray crystallographic analysis
68587 Mouse steroid sulfotransferases: substrate specificity and preliminary X-ray crystallographic analysis
68588 Mouse steroid sulfotransferases: substrate specificity and preliminary X-ray crystallographic analysis
68588 Mouse steroid sulfotransferases: substrate specificity and preliminary X-ray crystallographic analysis
68589 Mouse steroid sulfotransferases: substrate specificity and preliminary X-ray crystallographic analysis
68589 Mouse steroid sulfotransferases: substrate specificity and preliminary X-ray crystallographic analysis
68590 Mouse steroid sulfotransferases: substrate specificity and preliminary X-ray crystallographic analysis
68590 Mouse steroid sulfotransferases: substrate specificity and preliminary X-ray crystallographic analysis
68591 Mouse steroid sulfotransferases: substrate specificity and preliminary X-ray crystallographic analysis
68591 Mouse steroid sulfotransferases: substrate specificity and preliminary X-ray crystallographic analysis
68592 Mouse steroid sulfotransferases: substrate specificity and preliminary X-ray crystallographic analysis
68592 Mouse steroid sulfotransferases: substrate specificity and preliminary X-ray crystallographic analysis
68593 Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
68593 Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
68594 Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
68594 Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
68595 Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
68595 Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
68596 Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
68596 Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
68597 Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
68597 Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
68598 Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
68598 Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
68599 Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
68599 Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
68600 Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
68600 Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
68601 Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
68601 Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
68602 Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
68602 Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
68603 Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
68603 Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
68604 Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
68604 Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
68605 Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
68605 Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
68606 Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
68606 Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
68607 Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
68607 Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
68608 Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
68608 Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
68609 Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
68609 Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
68610 Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
68610 Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
68611 Porcine epidemic diarrhea virus papain-like protease 2 can be noncompetitively inhibited by 6-thioguanine
68611 Porcine epidemic diarrhea virus papain-like protease 2 can be noncompetitively inhibited by 6-thioguanine
68612 Porcine epidemic diarrhea virus papain-like protease 2 can be noncompetitively inhibited by 6-thioguanine
68612 Porcine epidemic diarrhea virus papain-like protease 2 can be noncompetitively inhibited by 6-thioguanine
68613 Porcine epidemic diarrhea virus papain-like protease 2 can be noncompetitively inhibited by 6-thioguanine
68613 Porcine epidemic diarrhea virus papain-like protease 2 can be noncompetitively inhibited by 6-thioguanine
68614 Porcine epidemic diarrhea virus papain-like protease 2 can be noncompetitively inhibited by 6-thioguanine
68614 Porcine epidemic diarrhea virus papain-like protease 2 can be noncompetitively inhibited by 6-thioguanine
68615 Porcine epidemic diarrhea virus papain-like protease 2 can be noncompetitively inhibited by 6-thioguanine
68615 Porcine epidemic diarrhea virus papain-like protease 2 can be noncompetitively inhibited by 6-thioguanine
68616 Porcine epidemic diarrhea virus papain-like protease 2 can be noncompetitively inhibited by 6-thioguanine
68616 Porcine epidemic diarrhea virus papain-like protease 2 can be noncompetitively inhibited by 6-thioguanine
68617 Porcine epidemic diarrhea virus papain-like protease 2 can be noncompetitively inhibited by 6-thioguanine
68617 Porcine epidemic diarrhea virus papain-like protease 2 can be noncompetitively inhibited by 6-thioguanine
68618 Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus
68618 Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus
68619 Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus
68619 Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus
68620 Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus
68620 Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus
68621 Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus
68621 Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus
68622 Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus
68622 Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus
68623 Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus
68623 Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus
68624 Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus
68624 Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus
68625 Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus
68625 Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus
68626 Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus
68626 Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus
68627 Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus
68627 Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus
68628 High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase
68628 High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase
68629 High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase
68629 High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase
68630 High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase
68630 High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase
68631 High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase
68631 High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase
68632 High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase
68632 High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase
68633 High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase
68633 High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase
68634 High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase
68634 High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase
68635 High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase
68635 High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase
68636 High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase
68636 High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase
68637 High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase
68637 High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase
68638 Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East ...
68638 Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East ...
68639 Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East ...
68639 Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East ...
68640 Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East ...
68640 Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East ...
68641 Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East ...
68641 Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East ...
68642 Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East ...
68642 Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East ...
68643 Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East ...
68643 Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East ...
68644 Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East ...
68644 Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East ...
68645 Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East ...
68645 Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East ...
68646 Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East ...
68646 Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East ...
68647 Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East ...
68647 Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East ...
68648 Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East ...
68648 Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East ...
68649 X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility ...
68649 X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility ...
68650 X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility ...
68650 X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility ...
68651 X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility ...
68651 X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility ...
68652 X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility ...
68652 X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility ...
68653 X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility ...
68653 X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility ...
68654 X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility ...
68654 X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility ...
68655 X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility ...
68655 X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility ...
68656 X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility ...
68656 X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility ...
68657 X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility ...
68657 X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility ...
68658 X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility ...
68658 X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility ...
68659 X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility ...
68659 X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility ...
68660 X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility ...
68660 X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility ...
68661 X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility ...
68661 X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility ...
68662 X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility ...
68662 X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility ...
68663 X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility ...
68663 X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility ...
68664 X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility ...
68664 X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility ...
68665 Conservation of the hydroxysteroid sulfotransferase SULT2B1 gene structure in the mouse: pre- and postnatal ...
68665 Conservation of the hydroxysteroid sulfotransferase SULT2B1 gene structure in the mouse: pre- and postnatal ...
68666 Conservation of the hydroxysteroid sulfotransferase SULT2B1 gene structure in the mouse: pre- and postnatal ...
68666 Conservation of the hydroxysteroid sulfotransferase SULT2B1 gene structure in the mouse: pre- and postnatal ...
68667 Conservation of the hydroxysteroid sulfotransferase SULT2B1 gene structure in the mouse: pre- and postnatal ...
68667 Conservation of the hydroxysteroid sulfotransferase SULT2B1 gene structure in the mouse: pre- and postnatal ...
68668 Conservation of the hydroxysteroid sulfotransferase SULT2B1 gene structure in the mouse: pre- and postnatal ...
68668 Conservation of the hydroxysteroid sulfotransferase SULT2B1 gene structure in the mouse: pre- and postnatal ...
68669 Conservation of the hydroxysteroid sulfotransferase SULT2B1 gene structure in the mouse: pre- and postnatal ...
68669 Conservation of the hydroxysteroid sulfotransferase SULT2B1 gene structure in the mouse: pre- and postnatal ...
68670 Conservation of the hydroxysteroid sulfotransferase SULT2B1 gene structure in the mouse: pre- and postnatal ...
68670 Conservation of the hydroxysteroid sulfotransferase SULT2B1 gene structure in the mouse: pre- and postnatal ...
68671 Conservation of the hydroxysteroid sulfotransferase SULT2B1 gene structure in the mouse: pre- and postnatal ...
68671 Conservation of the hydroxysteroid sulfotransferase SULT2B1 gene structure in the mouse: pre- and postnatal ...
68672 Conservation of the hydroxysteroid sulfotransferase SULT2B1 gene structure in the mouse: pre- and postnatal ...
68672 Conservation of the hydroxysteroid sulfotransferase SULT2B1 gene structure in the mouse: pre- and postnatal ...
68673 Geranyl diphosphate:4-hydroxybenzoate geranyltransferase from Lithospermum erythrorhizon. Cloning and ...
68673 Geranyl diphosphate:4-hydroxybenzoate geranyltransferase from Lithospermum erythrorhizon. Cloning and ...
68674 Geranyl diphosphate:4-hydroxybenzoate geranyltransferase from Lithospermum erythrorhizon. Cloning and ...
68674 Geranyl diphosphate:4-hydroxybenzoate geranyltransferase from Lithospermum erythrorhizon. Cloning and ...
68675 Geranyl diphosphate:4-hydroxybenzoate geranyltransferase from Lithospermum erythrorhizon. Cloning and ...
68675 Geranyl diphosphate:4-hydroxybenzoate geranyltransferase from Lithospermum erythrorhizon. Cloning and ...
68676 Geranyl diphosphate:4-hydroxybenzoate geranyltransferase from Lithospermum erythrorhizon. Cloning and ...
68676 Geranyl diphosphate:4-hydroxybenzoate geranyltransferase from Lithospermum erythrorhizon. Cloning and ...
68677 Crystal structures of ADP and AMPPNP-bound propionate kinase (TdcD) from Salmonella typhimurium: comparison ...
68677 Crystal structures of ADP and AMPPNP-bound propionate kinase (TdcD) from Salmonella typhimurium: comparison ...
68678 Crystal structures of ADP and AMPPNP-bound propionate kinase (TdcD) from Salmonella typhimurium: comparison ...
68678 Crystal structures of ADP and AMPPNP-bound propionate kinase (TdcD) from Salmonella typhimurium: comparison ...
68679 Crystal structures of ADP and AMPPNP-bound propionate kinase (TdcD) from Salmonella typhimurium: comparison ...
68679 Crystal structures of ADP and AMPPNP-bound propionate kinase (TdcD) from Salmonella typhimurium: comparison ...
68680 Regulation of the nonreceptor tyrosine kinase Brk by autophosphorylation and by autoinhibition
68680 Regulation of the nonreceptor tyrosine kinase Brk by autophosphorylation and by autoinhibition
68681 Regulation of the nonreceptor tyrosine kinase Brk by autophosphorylation and by autoinhibition
68681 Regulation of the nonreceptor tyrosine kinase Brk by autophosphorylation and by autoinhibition
68682 Regulation of the nonreceptor tyrosine kinase Brk by autophosphorylation and by autoinhibition
68682 Regulation of the nonreceptor tyrosine kinase Brk by autophosphorylation and by autoinhibition
68683 Regulation of the nonreceptor tyrosine kinase Brk by autophosphorylation and by autoinhibition
68683 Regulation of the nonreceptor tyrosine kinase Brk by autophosphorylation and by autoinhibition
68684 Regulation of the nonreceptor tyrosine kinase Brk by autophosphorylation and by autoinhibition
68684 Regulation of the nonreceptor tyrosine kinase Brk by autophosphorylation and by autoinhibition
68685 Long-range cooperative interactions modulate dimerization in SARS 3CLpro
68685 Long-range cooperative interactions modulate dimerization in SARS 3CLpro
68686 Long-range cooperative interactions modulate dimerization in SARS 3CLpro
68686 Long-range cooperative interactions modulate dimerization in SARS 3CLpro
68687 Long-range cooperative interactions modulate dimerization in SARS 3CLpro
68687 Long-range cooperative interactions modulate dimerization in SARS 3CLpro
68688 Long-range cooperative interactions modulate dimerization in SARS 3CLpro
68688 Long-range cooperative interactions modulate dimerization in SARS 3CLpro
68689 Long-range cooperative interactions modulate dimerization in SARS 3CLpro
68689 Long-range cooperative interactions modulate dimerization in SARS 3CLpro
68690 Long-range cooperative interactions modulate dimerization in SARS 3CLpro
68690 Long-range cooperative interactions modulate dimerization in SARS 3CLpro
68691 Long-range cooperative interactions modulate dimerization in SARS 3CLpro
68691 Long-range cooperative interactions modulate dimerization in SARS 3CLpro
68692 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68692 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68693 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68693 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68694 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68694 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68695 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68695 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68696 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68696 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68697 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68697 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68698 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68698 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68699 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68699 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68700 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68700 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68701 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68701 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68702 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68702 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68703 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68703 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68704 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68704 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68705 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68705 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68706 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68706 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68707 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68707 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68708 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68708 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68709 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68709 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68710 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68710 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68711 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68711 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68712 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68712 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68713 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68713 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68714 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68714 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68715 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68715 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68716 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68716 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68717 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68717 Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding ...
68718 Biosynthesis of pteridines in Escherichia coli. Structural and mechanistic similarity of ...
68718 Biosynthesis of pteridines in Escherichia coli. Structural and mechanistic similarity of ...
68719 Biosynthesis of pteridines in Escherichia coli. Structural and mechanistic similarity of ...
68719 Biosynthesis of pteridines in Escherichia coli. Structural and mechanistic similarity of ...
68720 Biosynthesis of pteridines in Escherichia coli. Structural and mechanistic similarity of ...
68720 Biosynthesis of pteridines in Escherichia coli. Structural and mechanistic similarity of ...
68721 Biosynthesis of pteridines in Escherichia coli. Structural and mechanistic similarity of ...
68721 Biosynthesis of pteridines in Escherichia coli. Structural and mechanistic similarity of ...
68722 Biosynthesis of pteridines in Escherichia coli. Structural and mechanistic similarity of ...
68722 Biosynthesis of pteridines in Escherichia coli. Structural and mechanistic similarity of ...
68723 Biosynthesis of pteridines in Escherichia coli. Structural and mechanistic similarity of ...
68723 Biosynthesis of pteridines in Escherichia coli. Structural and mechanistic similarity of ...
68724 Biosynthesis of pteridines in Escherichia coli. Structural and mechanistic similarity of ...
68724 Biosynthesis of pteridines in Escherichia coli. Structural and mechanistic similarity of ...
68725 Biosynthesis of pteridines in Escherichia coli. Structural and mechanistic similarity of ...
68725 Biosynthesis of pteridines in Escherichia coli. Structural and mechanistic similarity of ...
68726 Biosynthesis of pteridines in Escherichia coli. Structural and mechanistic similarity of ...
68726 Biosynthesis of pteridines in Escherichia coli. Structural and mechanistic similarity of ...
68727 Biosynthesis of pteridines in Escherichia coli. Structural and mechanistic similarity of ...
68727 Biosynthesis of pteridines in Escherichia coli. Structural and mechanistic similarity of ...
68728 Biosynthesis of pteridines in Escherichia coli. Structural and mechanistic similarity of ...
68728 Biosynthesis of pteridines in Escherichia coli. Structural and mechanistic similarity of ...
68729 Purification and properties of isocitrate dehydrogenase (NADP) from Thermus aquaticus YT-1, Bacillus ...
68729 Purification and properties of isocitrate dehydrogenase (NADP) from Thermus aquaticus YT-1, Bacillus ...
68730 Purification and properties of isocitrate dehydrogenase (NADP) from Thermus aquaticus YT-1, Bacillus ...
68730 Purification and properties of isocitrate dehydrogenase (NADP) from Thermus aquaticus YT-1, Bacillus ...
68731 Purification and properties of isocitrate dehydrogenase (NADP) from Thermus aquaticus YT-1, Bacillus ...
68731 Purification and properties of isocitrate dehydrogenase (NADP) from Thermus aquaticus YT-1, Bacillus ...
68732 Purification and properties of isocitrate dehydrogenase (NADP) from Thermus aquaticus YT-1, Bacillus ...
68732 Purification and properties of isocitrate dehydrogenase (NADP) from Thermus aquaticus YT-1, Bacillus ...
68733 Purification and properties of isocitrate dehydrogenase (NADP) from Thermus aquaticus YT-1, Bacillus ...
68733 Purification and properties of isocitrate dehydrogenase (NADP) from Thermus aquaticus YT-1, Bacillus ...
68734 Purification and properties of isocitrate dehydrogenase (NADP) from Thermus aquaticus YT-1, Bacillus ...
68734 Purification and properties of isocitrate dehydrogenase (NADP) from Thermus aquaticus YT-1, Bacillus ...
68735 Purification and properties of isocitrate dehydrogenase (NADP) from Thermus aquaticus YT-1, Bacillus ...
68735 Purification and properties of isocitrate dehydrogenase (NADP) from Thermus aquaticus YT-1, Bacillus ...
68736 Purification and properties of isocitrate dehydrogenase (NADP) from Thermus aquaticus YT-1, Bacillus ...
68736 Purification and properties of isocitrate dehydrogenase (NADP) from Thermus aquaticus YT-1, Bacillus ...
68737 Progress Curve Analysis Within BioCatNet: Comparing Kinetic Models for Enzyme-Catalyzed Self-Ligation
68737 Progress Curve Analysis Within BioCatNet: Comparing Kinetic Models for Enzyme-Catalyzed Self-Ligation
68738 Progress Curve Analysis Within BioCatNet: Comparing Kinetic Models for Enzyme-Catalyzed Self-Ligation
68738 Progress Curve Analysis Within BioCatNet: Comparing Kinetic Models for Enzyme-Catalyzed Self-Ligation
68739 Progress Curve Analysis Within BioCatNet: Comparing Kinetic Models for Enzyme-Catalyzed Self-Ligation
68739 Progress Curve Analysis Within BioCatNet: Comparing Kinetic Models for Enzyme-Catalyzed Self-Ligation
68740 Progress Curve Analysis Within BioCatNet: Comparing Kinetic Models for Enzyme-Catalyzed Self-Ligation
68740 Progress Curve Analysis Within BioCatNet: Comparing Kinetic Models for Enzyme-Catalyzed Self-Ligation
68741 Progress Curve Analysis Within BioCatNet: Comparing Kinetic Models for Enzyme-Catalyzed Self-Ligation
68741 Progress Curve Analysis Within BioCatNet: Comparing Kinetic Models for Enzyme-Catalyzed Self-Ligation
68742 Progress Curve Analysis Within BioCatNet: Comparing Kinetic Models for Enzyme-Catalyzed Self-Ligation
68742 Progress Curve Analysis Within BioCatNet: Comparing Kinetic Models for Enzyme-Catalyzed Self-Ligation
68743 Progress Curve Analysis Within BioCatNet: Comparing Kinetic Models for Enzyme-Catalyzed Self-Ligation
68743 Progress Curve Analysis Within BioCatNet: Comparing Kinetic Models for Enzyme-Catalyzed Self-Ligation
68744 Progress Curve Analysis Within BioCatNet: Comparing Kinetic Models for Enzyme-Catalyzed Self-Ligation
68744 Progress Curve Analysis Within BioCatNet: Comparing Kinetic Models for Enzyme-Catalyzed Self-Ligation
68745 Discovery of novel non- competitive inhibitors of mammalian neutral M1 aminopeptidase (APN)
68745 Discovery of novel non- competitive inhibitors of mammalian neutral M1 aminopeptidase (APN)
68746 Discovery of novel non- competitive inhibitors of mammalian neutral M1 aminopeptidase (APN)
68746 Discovery of novel non- competitive inhibitors of mammalian neutral M1 aminopeptidase (APN)
68747 Discovery of novel non- competitive inhibitors of mammalian neutral M1 aminopeptidase (APN)
68747 Discovery of novel non- competitive inhibitors of mammalian neutral M1 aminopeptidase (APN)
68748 Discovery of novel non- competitive inhibitors of mammalian neutral M1 aminopeptidase (APN)
68748 Discovery of novel non- competitive inhibitors of mammalian neutral M1 aminopeptidase (APN)
68749 Discovery of novel non- competitive inhibitors of mammalian neutral M1 aminopeptidase (APN)
68749 Discovery of novel non- competitive inhibitors of mammalian neutral M1 aminopeptidase (APN)
68750 Discovery of novel non- competitive inhibitors of mammalian neutral M1 aminopeptidase (APN)
68750 Discovery of novel non- competitive inhibitors of mammalian neutral M1 aminopeptidase (APN)
68751 Discovery of novel non- competitive inhibitors of mammalian neutral M1 aminopeptidase (APN)
68751 Discovery of novel non- competitive inhibitors of mammalian neutral M1 aminopeptidase (APN)
68752 Discovery of novel non- competitive inhibitors of mammalian neutral M1 aminopeptidase (APN)
68752 Discovery of novel non- competitive inhibitors of mammalian neutral M1 aminopeptidase (APN)
68753 Discovery of novel non- competitive inhibitors of mammalian neutral M1 aminopeptidase (APN)
68753 Discovery of novel non- competitive inhibitors of mammalian neutral M1 aminopeptidase (APN)
68754 Discovery of novel non- competitive inhibitors of mammalian neutral M1 aminopeptidase (APN)
68754 Discovery of novel non- competitive inhibitors of mammalian neutral M1 aminopeptidase (APN)
68755 Discovery of novel non- competitive inhibitors of mammalian neutral M1 aminopeptidase (APN)
68755 Discovery of novel non- competitive inhibitors of mammalian neutral M1 aminopeptidase (APN)
68756 Discovery of novel non- competitive inhibitors of mammalian neutral M1 aminopeptidase (APN)
68756 Discovery of novel non- competitive inhibitors of mammalian neutral M1 aminopeptidase (APN)
68757 Discovery of novel non- competitive inhibitors of mammalian neutral M1 aminopeptidase (APN)
68757 Discovery of novel non- competitive inhibitors of mammalian neutral M1 aminopeptidase (APN)
68758 Discovery of novel non- competitive inhibitors of mammalian neutral M1 aminopeptidase (APN)
68758 Discovery of novel non- competitive inhibitors of mammalian neutral M1 aminopeptidase (APN)
68759 Discovery of novel non- competitive inhibitors of mammalian neutral M1 aminopeptidase (APN)
68759 Discovery of novel non- competitive inhibitors of mammalian neutral M1 aminopeptidase (APN)
68760 Discovery of novel non- competitive inhibitors of mammalian neutral M1 aminopeptidase (APN)
68760 Discovery of novel non- competitive inhibitors of mammalian neutral M1 aminopeptidase (APN)
68761 Discovery of novel non- competitive inhibitors of mammalian neutral M1 aminopeptidase (APN)
68761 Discovery of novel non- competitive inhibitors of mammalian neutral M1 aminopeptidase (APN)
68762 Discovery of novel non- competitive inhibitors of mammalian neutral M1 aminopeptidase (APN)
68762 Discovery of novel non- competitive inhibitors of mammalian neutral M1 aminopeptidase (APN)
68763 Discovery of novel non- competitive inhibitors of mammalian neutral M1 aminopeptidase (APN)
68763 Discovery of novel non- competitive inhibitors of mammalian neutral M1 aminopeptidase (APN)
68764 Discovery of novel non- competitive inhibitors of mammalian neutral M1 aminopeptidase (APN)
68764 Discovery of novel non- competitive inhibitors of mammalian neutral M1 aminopeptidase (APN)
68765 Cyclohexanecarboxyl-coenzyme A (CoA) and cyclohex-1-ene-1-carboxyl-CoA dehydrogenases, two enzymes involved in ...
68765 Cyclohexanecarboxyl-coenzyme A (CoA) and cyclohex-1-ene-1-carboxyl-CoA dehydrogenases, two enzymes involved in ...
68766 Cyclohexanecarboxyl-coenzyme A (CoA) and cyclohex-1-ene-1-carboxyl-CoA dehydrogenases, two enzymes involved in ...
68766 Cyclohexanecarboxyl-coenzyme A (CoA) and cyclohex-1-ene-1-carboxyl-CoA dehydrogenases, two enzymes involved in ...
68767 Cyclohexanecarboxyl-coenzyme A (CoA) and cyclohex-1-ene-1-carboxyl-CoA dehydrogenases, two enzymes involved in ...
68767 Cyclohexanecarboxyl-coenzyme A (CoA) and cyclohex-1-ene-1-carboxyl-CoA dehydrogenases, two enzymes involved in ...
68768 Cyclohexanecarboxyl-coenzyme A (CoA) and cyclohex-1-ene-1-carboxyl-CoA dehydrogenases, two enzymes involved in ...
68768 Cyclohexanecarboxyl-coenzyme A (CoA) and cyclohex-1-ene-1-carboxyl-CoA dehydrogenases, two enzymes involved in ...
68769 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68769 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68770 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68770 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68771 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68771 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68772 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68772 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68773 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68773 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68774 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68774 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68775 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68775 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68776 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68776 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68777 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68777 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68778 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68778 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68779 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68779 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68780 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68780 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68781 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68781 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68782 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68782 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68783 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68783 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68784 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68784 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68785 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68785 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68786 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68786 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68787 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68787 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68788 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68788 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68789 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68789 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68790 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68790 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68791 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68791 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68792 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68792 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68793 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68793 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68794 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68794 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68795 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68795 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68796 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68796 Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent ...
68797 MGAT2, a monoacylglycerol acyltransferase expressed in the small intestine
68797 MGAT2, a monoacylglycerol acyltransferase expressed in the small intestine
68798 MGAT2, a monoacylglycerol acyltransferase expressed in the small intestine
68798 MGAT2, a monoacylglycerol acyltransferase expressed in the small intestine
68799 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68799 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68800 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68800 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68801 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68801 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68802 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68802 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68803 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68803 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68804 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68804 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68805 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68805 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68806 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68806 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68807 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68807 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68808 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68808 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68809 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68809 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68810 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68810 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68811 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68811 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68812 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68812 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68813 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68813 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68814 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68814 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68815 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68815 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68816 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68816 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68817 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68817 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68818 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68818 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68819 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68819 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68820 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68820 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68821 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68821 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68822 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68822 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68823 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68823 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68824 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68824 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68825 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68825 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68826 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68826 Aminoacylation of tRNA with phosphoserine for synthesis of cysteinyl-tRNA(Cys)
68827 Characterization of the alpha-ketoglutarate dehydrogenase complex from Fasciola hepatica: potential ...
68827 Characterization of the alpha-ketoglutarate dehydrogenase complex from Fasciola hepatica: potential ...
68828 Characterization of the alpha-ketoglutarate dehydrogenase complex from Fasciola hepatica: potential ...
68828 Characterization of the alpha-ketoglutarate dehydrogenase complex from Fasciola hepatica: potential ...
68829 Characterization of the alpha-ketoglutarate dehydrogenase complex from Fasciola hepatica: potential ...
68829 Characterization of the alpha-ketoglutarate dehydrogenase complex from Fasciola hepatica: potential ...
68830 Characterization of the alpha-ketoglutarate dehydrogenase complex from Fasciola hepatica: potential ...
68830 Characterization of the alpha-ketoglutarate dehydrogenase complex from Fasciola hepatica: potential ...
68831 Characterization of the alpha-ketoglutarate dehydrogenase complex from Fasciola hepatica: potential ...
68831 Characterization of the alpha-ketoglutarate dehydrogenase complex from Fasciola hepatica: potential ...
68832 Characterization of the alpha-ketoglutarate dehydrogenase complex from Fasciola hepatica: potential ...
68832 Characterization of the alpha-ketoglutarate dehydrogenase complex from Fasciola hepatica: potential ...
68833 Characterization of the alpha-ketoglutarate dehydrogenase complex from Fasciola hepatica: potential ...
68833 Characterization of the alpha-ketoglutarate dehydrogenase complex from Fasciola hepatica: potential ...
68834 Characterization of the alpha-ketoglutarate dehydrogenase complex from Fasciola hepatica: potential ...
68834 Characterization of the alpha-ketoglutarate dehydrogenase complex from Fasciola hepatica: potential ...
68835 Characterization of the alpha-ketoglutarate dehydrogenase complex from Fasciola hepatica: potential ...
68835 Characterization of the alpha-ketoglutarate dehydrogenase complex from Fasciola hepatica: potential ...
68836 Mutational analysis of a helicase motif-based RNA 5'-triphosphatase/NTPase from bamboo mosaic virus.
68836 Mutational analysis of a helicase motif-based RNA 5'-triphosphatase/NTPase from bamboo mosaic virus.
68837 Mutational analysis of a helicase motif-based RNA 5'-triphosphatase/NTPase from bamboo mosaic virus.
68837 Mutational analysis of a helicase motif-based RNA 5'-triphosphatase/NTPase from bamboo mosaic virus.
68838 Mutational analysis of a helicase motif-based RNA 5'-triphosphatase/NTPase from bamboo mosaic virus.
68838 Mutational analysis of a helicase motif-based RNA 5'-triphosphatase/NTPase from bamboo mosaic virus.
68839 Mutational analysis of a helicase motif-based RNA 5'-triphosphatase/NTPase from bamboo mosaic virus.
68839 Mutational analysis of a helicase motif-based RNA 5'-triphosphatase/NTPase from bamboo mosaic virus.
68840 Mutational analysis of a helicase motif-based RNA 5'-triphosphatase/NTPase from bamboo mosaic virus.
68840 Mutational analysis of a helicase motif-based RNA 5'-triphosphatase/NTPase from bamboo mosaic virus.
68841 Mutational analysis of a helicase motif-based RNA 5'-triphosphatase/NTPase from bamboo mosaic virus.
68841 Mutational analysis of a helicase motif-based RNA 5'-triphosphatase/NTPase from bamboo mosaic virus.
68842 Mutational analysis of a helicase motif-based RNA 5'-triphosphatase/NTPase from bamboo mosaic virus.
68842 Mutational analysis of a helicase motif-based RNA 5'-triphosphatase/NTPase from bamboo mosaic virus.
68843 Mutational analysis of a helicase motif-based RNA 5'-triphosphatase/NTPase from bamboo mosaic virus.
68843 Mutational analysis of a helicase motif-based RNA 5'-triphosphatase/NTPase from bamboo mosaic virus.
68844 Mutational analysis of a helicase motif-based RNA 5'-triphosphatase/NTPase from bamboo mosaic virus.
68844 Mutational analysis of a helicase motif-based RNA 5'-triphosphatase/NTPase from bamboo mosaic virus.
68845 Mutational analysis of a helicase motif-based RNA 5'-triphosphatase/NTPase from bamboo mosaic virus.
68845 Mutational analysis of a helicase motif-based RNA 5'-triphosphatase/NTPase from bamboo mosaic virus.
68846 Mutational analysis of a helicase motif-based RNA 5'-triphosphatase/NTPase from bamboo mosaic virus.
68846 Mutational analysis of a helicase motif-based RNA 5'-triphosphatase/NTPase from bamboo mosaic virus.
68847 Mutational analysis of a helicase motif-based RNA 5'-triphosphatase/NTPase from bamboo mosaic virus.
68847 Mutational analysis of a helicase motif-based RNA 5'-triphosphatase/NTPase from bamboo mosaic virus.
68848 Isolation and characterization of two tryptophan biosynthetic enzymes, indoleglycerol phosphate synthase and ...
68848 Isolation and characterization of two tryptophan biosynthetic enzymes, indoleglycerol phosphate synthase and ...
68849 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68849 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68850 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68850 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68851 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68851 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68852 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68852 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68853 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68853 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68854 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68854 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68855 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68855 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68856 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68856 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68857 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68857 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68858 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68858 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68859 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68859 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68860 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68860 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68861 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68861 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68862 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68862 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68863 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68863 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68864 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68864 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68865 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68865 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68866 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68866 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68867 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68867 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68868 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68868 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68869 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68869 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68870 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68870 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68871 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68871 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68872 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68872 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68873 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68873 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68874 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68874 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68875 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68875 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68876 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68876 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68877 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68877 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68878 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68878 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68879 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68879 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68880 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68880 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68881 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68881 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68882 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68882 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68883 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68883 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68884 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68884 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68885 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68885 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68886 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68886 The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase ...
68887 Regulatory properties of a plant NAD: isocitrate dehydrogenase. The effect of inorganic ions.
68887 Regulatory properties of a plant NAD: isocitrate dehydrogenase. The effect of inorganic ions.
68888 Regulatory properties of a plant NAD: isocitrate dehydrogenase. The effect of inorganic ions.
68888 Regulatory properties of a plant NAD: isocitrate dehydrogenase. The effect of inorganic ions.
68889 Regulatory properties of a plant NAD: isocitrate dehydrogenase. The effect of inorganic ions.
68889 Regulatory properties of a plant NAD: isocitrate dehydrogenase. The effect of inorganic ions.
68890 Regulatory properties of a plant NAD: isocitrate dehydrogenase. The effect of inorganic ions.
68890 Regulatory properties of a plant NAD: isocitrate dehydrogenase. The effect of inorganic ions.
68891 Regulatory properties of a plant NAD: isocitrate dehydrogenase. The effect of inorganic ions.
68891 Regulatory properties of a plant NAD: isocitrate dehydrogenase. The effect of inorganic ions.
68892 Regulatory properties of a plant NAD: isocitrate dehydrogenase. The effect of inorganic ions.
68892 Regulatory properties of a plant NAD: isocitrate dehydrogenase. The effect of inorganic ions.
68893 Regulatory properties of a plant NAD: isocitrate dehydrogenase. The effect of inorganic ions.
68893 Regulatory properties of a plant NAD: isocitrate dehydrogenase. The effect of inorganic ions.
68894 Regulatory properties of a plant NAD: isocitrate dehydrogenase. The effect of inorganic ions.
68894 Regulatory properties of a plant NAD: isocitrate dehydrogenase. The effect of inorganic ions.
68895 Regulatory properties of a plant NAD: isocitrate dehydrogenase. The effect of inorganic ions.
68895 Regulatory properties of a plant NAD: isocitrate dehydrogenase. The effect of inorganic ions.
68896 Regulatory properties of a plant NAD: isocitrate dehydrogenase. The effect of inorganic ions.
68896 Regulatory properties of a plant NAD: isocitrate dehydrogenase. The effect of inorganic ions.
68897 Regulatory properties of a plant NAD: isocitrate dehydrogenase. The effect of inorganic ions.
68897 Regulatory properties of a plant NAD: isocitrate dehydrogenase. The effect of inorganic ions.
68898 Regulatory properties of a plant NAD: isocitrate dehydrogenase. The effect of inorganic ions.
68898 Regulatory properties of a plant NAD: isocitrate dehydrogenase. The effect of inorganic ions.
68899 Relationship of Catalysis and Active Site Loop Dynamics in the (βα)(8)-Barrel Enzyme Indole-3-glycerol ...
68899 Relationship of Catalysis and Active Site Loop Dynamics in the (βα)(8)-Barrel Enzyme Indole-3-glycerol ...
68900 Relationship of Catalysis and Active Site Loop Dynamics in the (βα)(8)-Barrel Enzyme Indole-3-glycerol ...
68900 Relationship of Catalysis and Active Site Loop Dynamics in the (βα)(8)-Barrel Enzyme Indole-3-glycerol ...
68901 Relationship of Catalysis and Active Site Loop Dynamics in the (βα)(8)-Barrel Enzyme Indole-3-glycerol ...
68901 Relationship of Catalysis and Active Site Loop Dynamics in the (βα)(8)-Barrel Enzyme Indole-3-glycerol ...
68902 Relationship of Catalysis and Active Site Loop Dynamics in the (βα)(8)-Barrel Enzyme Indole-3-glycerol ...
68902 Relationship of Catalysis and Active Site Loop Dynamics in the (βα)(8)-Barrel Enzyme Indole-3-glycerol ...
68903 Relationship of Catalysis and Active Site Loop Dynamics in the (βα)(8)-Barrel Enzyme Indole-3-glycerol ...
68903 Relationship of Catalysis and Active Site Loop Dynamics in the (βα)(8)-Barrel Enzyme Indole-3-glycerol ...
68904 Relationship of Catalysis and Active Site Loop Dynamics in the (βα)(8)-Barrel Enzyme Indole-3-glycerol ...
68904 Relationship of Catalysis and Active Site Loop Dynamics in the (βα)(8)-Barrel Enzyme Indole-3-glycerol ...
68905 Purification and characterization of the indole-3-glycerolphosphate synthase/anthranilate synthase complex of ...
68905 Purification and characterization of the indole-3-glycerolphosphate synthase/anthranilate synthase complex of ...
68906 Purification and characterization of the indole-3-glycerolphosphate synthase/anthranilate synthase complex of ...
68906 Purification and characterization of the indole-3-glycerolphosphate synthase/anthranilate synthase complex of ...
68907 Purification and characterization of the indole-3-glycerolphosphate synthase/anthranilate synthase complex of ...
68907 Purification and characterization of the indole-3-glycerolphosphate synthase/anthranilate synthase complex of ...
68908 Purification and characterization of the indole-3-glycerolphosphate synthase/anthranilate synthase complex of ...
68908 Purification and characterization of the indole-3-glycerolphosphate synthase/anthranilate synthase complex of ...
68909 Purification and characterization of the indole-3-glycerolphosphate synthase/anthranilate synthase complex of ...
68909 Purification and characterization of the indole-3-glycerolphosphate synthase/anthranilate synthase complex of ...
68910 Purification and characterization of the indole-3-glycerolphosphate synthase/anthranilate synthase complex of ...
68910 Purification and characterization of the indole-3-glycerolphosphate synthase/anthranilate synthase complex of ...
68911 Purification and characterization of the indole-3-glycerolphosphate synthase/anthranilate synthase complex of ...
68911 Purification and characterization of the indole-3-glycerolphosphate synthase/anthranilate synthase complex of ...
68912 Purification and properties of diphosphopyridine nuleotide-linked isocitrate dehydrogenase of mammalian liver.
68912 Purification and properties of diphosphopyridine nuleotide-linked isocitrate dehydrogenase of mammalian liver.
68913 Purification and properties of diphosphopyridine nuleotide-linked isocitrate dehydrogenase of mammalian liver.
68913 Purification and properties of diphosphopyridine nuleotide-linked isocitrate dehydrogenase of mammalian liver.
68914 Purification and properties of diphosphopyridine nuleotide-linked isocitrate dehydrogenase of mammalian liver.
68914 Purification and properties of diphosphopyridine nuleotide-linked isocitrate dehydrogenase of mammalian liver.
68915 Purification and properties of diphosphopyridine nuleotide-linked isocitrate dehydrogenase of mammalian liver.
68915 Purification and properties of diphosphopyridine nuleotide-linked isocitrate dehydrogenase of mammalian liver.
68916 Purification and properties of diphosphopyridine nuleotide-linked isocitrate dehydrogenase of mammalian liver.
68916 Purification and properties of diphosphopyridine nuleotide-linked isocitrate dehydrogenase of mammalian liver.
68917 Purification and properties of diphosphopyridine nuleotide-linked isocitrate dehydrogenase of mammalian liver.
68917 Purification and properties of diphosphopyridine nuleotide-linked isocitrate dehydrogenase of mammalian liver.
68918 Purification and properties of diphosphopyridine nuleotide-linked isocitrate dehydrogenase of mammalian liver.
68918 Purification and properties of diphosphopyridine nuleotide-linked isocitrate dehydrogenase of mammalian liver.
68919 Purification and properties of diphosphopyridine nuleotide-linked isocitrate dehydrogenase of mammalian liver.
68919 Purification and properties of diphosphopyridine nuleotide-linked isocitrate dehydrogenase of mammalian liver.
68920 Purification and properties of diphosphopyridine nuleotide-linked isocitrate dehydrogenase of mammalian liver.
68920 Purification and properties of diphosphopyridine nuleotide-linked isocitrate dehydrogenase of mammalian liver.
68921 Purification and properties of diphosphopyridine nuleotide-linked isocitrate dehydrogenase of mammalian liver.
68921 Purification and properties of diphosphopyridine nuleotide-linked isocitrate dehydrogenase of mammalian liver.
68922 Purification and properties of diphosphopyridine nuleotide-linked isocitrate dehydrogenase of mammalian liver.
68922 Purification and properties of diphosphopyridine nuleotide-linked isocitrate dehydrogenase of mammalian liver.
68923 Purification and properties of diphosphopyridine nuleotide-linked isocitrate dehydrogenase of mammalian liver.
68923 Purification and properties of diphosphopyridine nuleotide-linked isocitrate dehydrogenase of mammalian liver.
68924 Purification and properties of diphosphopyridine nuleotide-linked isocitrate dehydrogenase of mammalian liver.
68924 Purification and properties of diphosphopyridine nuleotide-linked isocitrate dehydrogenase of mammalian liver.
68925 Purification and properties of diphosphopyridine nuleotide-linked isocitrate dehydrogenase of mammalian liver.